<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="72.057,74.463,78.587,82.711,85.117,88.44,94.193,96.211,99.476,100.855,104.98,106.997,108.396,114.15,116.167,119.903,124.028,127.76400000000001,129.201,134.954,140.319,142.33599999999998,143.714,149.078,153.203,156.939,161.063,164.79899999999998,166.219,169.095,174.46,176.477,177.896,181.161,183.567,184.983,188.718,190.736,192.753,194.109,201.581,204.846,207.252,211.456,215.192,217.209,220.945,223.351,225.368,229.493,233.618,235.038,239.164,241.57,242.919,245.795,249.061,251.467,253.484,257.608,261.733,263.837,267.102,268.486,272.222,275.487,277.504,281.629,282.998,285.875,289.14,292.405,295.67,299.795,302.201,306.41" y="37.76400000000001" svg_rhmargin="309.287" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[23] Xie F, Xiang XY, Zhang JC, et al. Methylation of retinoic acid receptor</text>
  <text x="309.315" y="37.76400000000001" svg_rhmargin="313.903" style="fill:#171615;font-family:LJLAKN+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">b</text>
  <text x="313.909" y="39.01099999999997" svg_rhmargin="317.002" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:4.98px;font-style:NORMAL;font-weight:normal;">2</text>
  <text x="88.441,92.565,95.442,99.566,105.708,109.833,112.239,115.504,118.381,120.583,122.6,126.725,128.916,131.793,135.917,140.042,142.919,146.654,150.779,152.796,156.06099999999998,158.281,162.405,165.282,168.547,172.283,175.159,177.565,179.766,183.031,186.767,190.891,194.156,197.422,200.299,202.498,204.904,206.921,209.798,212.675,216.799,220.064,222.081,224.266,229.631,233.367,237.491,240.757,244.107,246.984,249.153,254.517,257.783,260.66,262.815,266.939,269.816,273.081,276.817,279.028,283.929,286.806,290.071,293.807,296.213,298.416,302.54,306.665,310.789,314.913" y="46.721000000000004" svg_rhmargin="316.93" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">promoter in sporadic breast cancer tissue. Cancer Res Prev Treat 2011;</text>
  <text x="88.441,92.566,96.691,98.709,102.835,106.96" y="55.678999999999974" svg_rhmargin="111.084" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">38:408</text>
  <text x="111.118" y="55.678999999999974" svg_rhmargin="114.854" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="114.86,118.985,123.11" y="55.678999999999974" svg_rhmargin="125.127" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">15.</text>
  <text x="72.057,74.463,78.587,82.712,85.11800000000001,88.44,94.193,98.318,102.443,108.196,110.213,114.348,118.084,122.208,126.333,130.505,133.382,138.746,140.763,144.904,150.657,154.782,158.907,163.42,165.43699999999998,169.564,172.83,175.23600000000002,179.372,183.108,185.125,187.142,191.334,195.847,199.971,201.988,205.724,208.989,213.114,216.379,218.785,220.802,224.06699999999998,228.238,231.114,234.379,238.115,242.24,244.257,247.993,250.399,252.416,256.541,260.666,264.858,268.983,271.389,275.516,278.393,281.658,284.064,286.081,290.206,294.33,296.347,299.61199999999997,303.803,307.539,310.805,312.822" y="64.63599999999997" svg_rhmargin="316.946" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[24] Xu X, Sun JY, Gu L, et al. Epigenetic regulation of retinoic acid</text>
  <text x="88.441,91.318,94.583,97.848,101.113,105.237,107.643,111.768" y="73.59299999999996" svg_rhmargin="114.645" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">receptor</text>
  <text x="114.689" y="73.59299999999996" svg_rhmargin="119.277" style="fill:#171615;font-family:LJLAKN+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">b</text>
  <text svg_rhmargin="122.375" x="119.282,122.375" y="73.59400000000005" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:4.98px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text x="124.044,127.78,131.045,135.17,138.43499999999997,140.087,142.104,146.229,147.911,150.316,154.441,157.706,159.419,162.684,166.42,169.296,172.562,174.579,178.703,182.828,186.564,189.829,193.953,197.218,200.095,202.112,204.989,206.696,210.821,213.227,214.916,219.041,221.917,225.182,228.918,231.795,234.201,235.891,239.156,242.892,247.017,250.282,253.547,256.424,258.441,260.153,265.518,269.643,271.66,275.785,277.5,280.377,282.035,287.4,289.418,291.435,295.56,297.228,303.37,307.494,310.759,314.884" y="73.59400000000005" svg_rhmargin="316.901" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">gene in the carcinogenesis of breast cancer. Chin J Clin Oncol</text>
  <text x="88.441,92.566,96.691,100.817,104.942,106.96,111.085,115.21,117.228,121.354,125.479,129.604" y="82.55100000000004" svg_rhmargin="133.728" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2010;37:1326</text>
  <text x="133.795" y="82.55100000000004" svg_rhmargin="137.531" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="137.48,141.605,145.73" y="82.55100000000004" svg_rhmargin="147.747" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">33.</text>
  <text x="72.057,74.463,78.587,82.712,85.11800000000001,88.44,92.953,96.689,100.425,104.161,108.285,110.30199999999999,113.043,116.779,122.143,124.16,126.931,131.056,133.932,137.668,140.545,144.281,148.406,151.194,156.559,160.684,162.701,165.48,170.844,174.58,178.705,181.58200000000002,184.357,187.234,189.251,192.011,195.276,197.68200000000002,200.401,204.137,206.154,208.171,210.945,216.31,218.327,220.344,224.469,226.486,229.751,233.487,235.504,238.325,241.202,243.219,246.955,251.08" y="91.56500000000005" svg_rhmargin="253.097" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[25] Bagadi SA, Prasad CP, Kaur J, et al. Clinical signi</text>
  <text x="253.133" y="91.56500000000005" svg_rhmargin="257.257" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="257.272,260.537,264.273,268.397,271.662,274.92699999999996,277.679,281.804,284.21,286.976,291.101,293.977,298.102,304.244,308.368,310.774,314.039" y="91.56500000000005" svg_rhmargin="316.916" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance of promoter</text>
  <text x="88.441,92.565,96.301,100.426,103.691,106.568,112.709,115.975,118.381,122.505,126.241,128.258,131.994,134.4,136.417,140.542,144.667,148.36,152.485,154.89100000000002,158.508,163.873,169.237,172.973,176.709,180.834,185.038,190.403,192.42,196.036,201.4,206.765,212.13,216.254,219.52,221.925,225.661,229.878,231.89499999999998,235.491,240.004,245.369,250.734,256.098,260.223,263.892,267.628,271.753,275.878,279.539,285.763,291.905,297.658,303.023,307.148,310.774,312.791" y="100.52200000000005" svg_rhmargin="316.915" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in</text>
  <text x="88.441,92.565,95.442,98.707,102.443,105.32,107.726,110.209,113.475,117.21,121.335,124.665,127.93,130.807,133.684,136.173,140.298,142.704,145.187,147.593,151.717,155.842,157.859,161.595,165.72,168.259,172.384,176.12,178.525,180.543,183.808,187.932,190.338,193.215,195.232,197.794,202.307,204.324,206.73,209.99499999999998,212.533,216.269,219.534,221.551,224.041,228.165,232.29,236.414,240.538,242.556,246.68,250.805,252.822,256.947,261.071,265.195" y="109.47900000000004" svg_rhmargin="269.319" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast cancers of Indian patients. Life Sci 2008;82:1288</text>
  <text x="269.404" y="109.47900000000004" svg_rhmargin="273.14" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="273.145,277.27,281.394" y="109.47900000000004" svg_rhmargin="283.411" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">92.</text>
  <text x="72.057,74.463,78.587,82.712,85.11800000000001,88.44,93.805,97.929,102.054,106.178,109.914,112.791,116.056,119.792,122.283,128.036,131.772,133.789,136.342,140.855,144.979,148.715,150.733,154.857,158.982,162.718,165.197,170.561,172.967,174.984,177.555,181.679,184.556,188.68,192.805,194.822,198.947,202.683,205.162,207.568,212.933,214.95,217.464,220.729,223.13500000000002,225.684,229.42,231.438,233.45499999999998,235.946,243.417,246.682,249.088,253.213,256.949,258.966,262.702,265.108,267.125,271.25,275.375,277.951,282.076,284.482,286.966,291.091,293.968,298.092,304.234,308.358,310.764,314.029" y="118.43700000000001" svg_rhmargin="316.906" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Khodyrev DS, Loginov VI, Pronina IV, et al. Methylation of promoter</text>
  <text x="88.441,91.318,94.583,98.319,100.336,104.461,108.586,110.663,114.788,117.194,119.224,124.589,129.954,135.318,137.724,141.849,145.114,147.52,151.256,155.381,157.489,161.225,164.49,168.614,171.879,173.929,175.946,180.071,182.149,185.026,188.291,192.416,196.152,198.16899999999998,200.233,203.499,206.764,208.781,210.798,212.815,214.859,218.984,221.86,225.126,228.862,231.738,234.144,236.161,238.272,242.007,246.132,250.257,252.274,256.399,260.135,263.871,266.747,268.765,272.501,276.626,278.691,281.956,285.692,288.569,291.834,293.851,297.976,302.1,308.242,311.978,314.854" y="127.394" svg_rhmargin="316.871" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">region of RAR-beta2 gene in renal cell, breast, and ovarian carcinomas.</text>
  <text x="88.441,94.194,97.459,101.584,104.849,107.255,109.272,113.397,117.13300000000001,119.676,123.801,127.925,132.049,136.174,138.191,142.316,146.44,148.457,152.582,156.706,160.831" y="136.351" svg_rhmargin="164.955" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Genetika 2008;44:1126</text>
  <text x="165.033" y="136.351" svg_rhmargin="168.769" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="168.775,172.9,177.025" y="136.351" svg_rhmargin="179.042" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="72.058,74.464,78.588,82.712,85.11800000000001,88.441,92.177,96.301,100.426,104.55,106.568,110.304,111.91,115.646,117.663,119.279,126.752,128.769,131.646,134.911,138.647,140.312,144.048,146.065,147.681,151.417,155.542,159.277,162.154,168.296,172.03199999999998,173.644,179.398,181.415,183.056,186.321,188.727,190.369,194.105,196.122,198.139,199.723,205.476,208.741,211.147,214.413,217.678,220.188,222.205,226.329,230.454,232.036,236.16,238.566,240.199,245.564,250.929,254.665,258.401,262.525,266.649,272.014,273.645,277.381,281.506,285.631,287.251,292.615,297.98,303.345,307.545,310.81,313.216" y="145.365" svg_rhmargin="316.952" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[27] Shukla S, Mirza S, Sharma G, et al. Detection of RASSF1A and RARbeta</text>
  <text x="88.442,92.566,96.302,100.427,103.692,106.568,112.71,115.975,118.381,122.506,126.242,128.259,131.995,134.401,136.418,140.543,144.668,146.15,148.168,152.293,153.69,156.567,159.832,162.708,166.833,172.975,174.438,180.192,186.334,191.699,193.146,195.551,198.428,202.553,208.695,210.152,214.277,217.154,220.419,224.155,227.032,229.43800000000002,230.844,234.109,237.845,241.969,245.3,248.565,251.442,252.839,256.964,260.7,263.106,265.123,268.388,272.513,274.918,277.795,279.812,281.296,285.809,289.934,291.951,295.687,298.952,303.077,306.342,308.748,310.765,314.03" y="154.322" svg_rhmargin="316.907" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">hypermethylation in serum DNA from breast cancer patients. Epigenetics</text>
  <text x="88.442,92.567,96.692,100.817,104.942,106.961,111.086,113.104,117.229" y="163.27999999999997" svg_rhmargin="121.353" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2006;1:88</text>
  <text x="121.38" y="163.27999999999997" svg_rhmargin="125.116" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="125.122,129.247,133.373" y="163.27999999999997" svg_rhmargin="135.39" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">93.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,92.955,96.22,101.973,103.991,106.868,108.566,113.931,121.403,123.42,125.119,130.484,132.501,135.767,138.644,140.369,144.882,150.246,152.263,153.917,158.43,162.555,164.292,170.045,177.517,179.534,181.185,184.45,186.856,188.554,192.29,194.307,196.32399999999998,198.021,202.145,205.022,209.146,215.288,219.413,221.819,225.084,227.961,229.71,233.834,237.57,241.694,244.96,247.836,253.978,257.243,259.649,263.773,267.509,269.527,273.263,275.669,277.686,281.919,286.044,287.701,289.719,293.844,295.525,299.649,302.914,307.039,309.056,312.792" y="172.23699999999997" svg_rhmargin="316.916" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[28] Lewis CM, Cler LR, Bu DW, et al. Promoter hypermethylation in benign</text>
  <text x="88.442,92.567,95.444,98.709,102.445,105.321,107.727,109.644,112.909,117.033,119.051,121.457,125.581,128.846,130.864,132.881,137.005,143.147,145.074,147.092,151.217,153.124,156.001,159.266,161.284,165.019,167.425,169.443,173.567,177.692,179.598,182.004,186.129,187.988,192.112,194.989,198.254,202.443,204.461,207.726,210.132,213.397,217.522,219.393,223.518,226.394,229.66,233.395,236.272,238.678,240.594,243.86,247.596,251.72,254.985,258.25,261.127,263.043,265.919,267.937,270.813,274.938,276.955,278.859,284.225,286.242,288.259,292.384,294.279,299.644,303.38,307.504,310.77,314.035" y="181.19399999999996" svg_rhmargin="316.912" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast epithelium in relation to predicted breast cancer risk. Clin Cancer</text>
  <text x="88.442,93.808,97.074,99.951,102.446,106.571,110.697,114.822,118.947,120.965,125.09,129.215,131.305,135.43,139.556" y="190.15099999999995" svg_rhmargin="143.68" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Res 2005;11:166</text>
  <text x="143.661" y="190.15099999999995" svg_rhmargin="147.397" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="147.403,151.528,155.654" y="190.15099999999995" svg_rhmargin="157.671" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">72.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.443,92.567,96.303,99.568,103.692,105.71,108.975,111.85199999999999,113.555,121.027,123.904,125.92099999999999,127.614,135.087,138.352,143.717,147.059,149.076,152.812,156.937,158.624,166.095,168.112,169.792,174.305,178.041,180.917,185.042,189.167,190.88,195.393,197.41,199.157,202.422,204.828,206.526,210.262,212.279,214.296,215.994,221.747,227.889,233.25400000000002,234.985,241.126,244.392,246.798,250.922,254.658,256.675,260.411,262.817,264.835,268.959,273.084,274.836,278.961,281.367,283.056,288.421,293.785,297.521,301.257,305.382,309.506,314.871" y="199.10799999999995" svg_rhmargin="316.888" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[29] Fackler MJ, McVeigh M, Evron E, et al. DNA methylation of RASSF1A,</text>
  <text x="88.443,94.667,97.073,103.215,105.621,109.745,111.762,114.18,119.545,124.909,130.274,132.68,136.804,140.07,142.476,146.211,148.228,150.687,156.052,159.788,163.053,165.07,167.088,171.213,173.646,179.4,183.525,185.891,189.627,193.752,197.877,200.29,205.192,210.945,212.962,215.839,218.245,220.698,222.715,226.84,229.201,231.219,235.344,237.762,240.639,242.656,245.062,249.187,251.594,255.33,259.455,263.58,265.937,267.954,272.078,275.814,279.55,282.427,284.444,288.18,291.445,293.884,295.901,300.026,304.15,308.275,310.292,314.028" y="208.12199999999996" svg_rhmargin="316.905" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular</text>
  <text x="88.443,92.568,95.444,98.71,102.445,105.322,107.72800000000001,110.212,113.477,117.213,120.089,123.354,125.372,129.496,133.621,139.86,143.596,145.613,148.079,150.485,154.61,157.01600000000002,159.531,162.40800000000002,164.916,170.281,174.017,178.141,181.407,184.672,187.549,190.086,194.21,198.335,202.459,206.584,208.601,212.725,216.85,220.974,222.992,227.116,231.241" y="217.08000000000004" svg_rhmargin="235.365" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast carcinoma. Int J Cancer 2003;107:970</text>
  <text x="235.447" y="217.08000000000004" svg_rhmargin="239.183" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="239.189,243.314" y="217.08000000000004" svg_rhmargin="245.331" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.443,95.914,97.932,102.056,104.933,108.198,112.322,118.076,121.341,125.465,129.59,131.996,135.261,138.138,142.579,150.051,152.06799999999998,156.469,160.982,164.247,167.124,170.859,174.125,177.002,181.412,184.289,186.30599999999998,190.709,198.181,202.305,204.323,206.34,209.605,212.482,216.899,223.123,230.595,232.612,236.967,240.232,242.638,247.058,250.794,252.811,254.828,259.19,263.703,267.827,269.844,273.645,276.91,281.035,284.3,286.706,288.723,291.988,296.377,300.502,304.626,310.38,314.504" y="226.03700000000003" svg_rhmargin="316.91" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[30] Widschwendter M, Berger J, Muller HM, et al. Epigenetic down-</text>
  <text x="88.443,91.32,94.585,98.321,102.445,104.463,108.199,110.605,112.622,116.746,120.871,123.987,128.111,130.517,133.567,135.973,140.097,143.362,146.492,149.369,152.634,155.04,157.058,161.182,165.306,167.324,170.589,173.703,177.439,180.704,182.722,186.847,189.916,192.793,196.058,199.323,202.588,206.713,209.119,213.243,216.12,218.526,222.738,226.004,228.41,232.145,236.27,239.348,243.084,246.349,250.474,253.73899999999998,256.808,258.826,262.951,266.049,270.174,273.051,276.316,280.052,282.928,285.334,288.385,291.65,295.386,299.51,302.841,306.106,308.982,310.999,314.065" y="234.99400000000003" svg_rhmargin="316.942" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">regulation of the retinoic acid receptor-beta2 gene in breast cancer. J</text>
  <text x="88.443,95.915,99.651,105.793,111.935,115.671,118.547,122.283,124.78,130.533,132.551,136.287,140.483,144.608,147.06,151.573,153.591,157.715,159.732,162.253,168.395,171.66,175.785,179.909,181.927,185.663,188.539,190.654,194.39,196.833,200.957,205.082,209.206,213.331,215.427,219.552,221.569,225.694,229.818" y="243.95100000000002" svg_rhmargin="233.942" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Mammary Gland Biol Neoplasia 2001;6:193</text>
  <text x="233.973" y="243.95100000000002" svg_rhmargin="237.709" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="237.715,241.84,245.965,250.09" y="243.95100000000002" svg_rhmargin="252.107" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">201.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.443,92.955,97.08,100.816,104.081,108.205,111.471,113.488,117.013,122.378,124.395,127.897,132.41,135.67499999999998,139.122,145.264,149.777,151.79399999999998,155.335,160.7,164.824,167.23,170.49499999999998,173.986,177.722,179.739,183.227,186.492,188.898,192.41,196.146,198.164,200.18099999999998,203.692,209.445,215.587,220.952,224.497,230.639,233.904,236.31,240.435,244.17,246.188,249.924,252.33,254.347,258.471,262.596,266.106,270.231,272.637,276.14,279.017,282.282,284.688,286.705,290.83,294.954,297.058,300.323,303.804,307.54,310.805,312.823" y="252.90800000000002" svg_rhmargin="316.947" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[31] Bovenzi V, Le NL, Cote S, et al. DNA methylation of retinoic acid</text>
  <text x="88.443,91.32,94.585,97.85,101.115,105.24,107.646,111.77,114.64699999999999,116.901,121.026,124.291,126.697,130.433,132.717,134.735,138.86,141.107,145.232,148.109,151.374,155.11,157.986,160.392,162.649,165.915,169.651,173.775,177.105,180.37,183.247,185.495,189.231,193.356,197.481,199.725,203.849,207.973,210.85,213.727,215.744,219.869,221.886,225.15099999999998,227.445,229.851,233.975,237.24,240.117,243.853,247.977,251.243,255.367,257.773,259.79,263.055,265.37,268.246,272.371,274.388,277.65299999999996,279.882,284.006,286.412,288.669,292.793,295.199,298.935,302.2,305.936,308.342" y="261.922" svg_rhmargin="312.466" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">receptor beta in breast cancer and possible therapeutic role of 5-aza-2</text>
  <text x="312.549" y="261.922" svg_rhmargin="314.566" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="314.534" y="261.922" svg_rhmargin="316.94" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="88.444,92.568,95.834,99.958,104.082,107.818,111.084,114.819,117.225,119.243,123.367,125.385,129.509,132.774,134.791,137.366,142.73,146.855,149.261,151.278,154.543,158.279,162.404,165.669,168.934,171.811,174.326,180.08,182.956,187.081,190.817,193.69400000000002,196.265,200.39,204.514,208.638,212.763,214.78,218.905,223.029,225.046,229.171,233.295" y="270.88" svg_rhmargin="237.419" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">deoxycytidine. Anticancer Drugs 1999;10:471</text>
  <text x="237.488" y="270.88" svg_rhmargin="241.224" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="241.174,245.298" y="270.88" svg_rhmargin="247.315" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">6.</text>
  <text x="72.06,74.466,78.59,82.715,85.12100000000001,88.443,94.197,96.214,99.479,103.352,107.478,109.49499999999999,113.387,118.752,122.876,126.612,130.737,134.47299999999998,138.33,143.695,148.208,150.225,154.147,160.288,164.413,168.149,171.885,176.009,179.74499999999998,183.624,186.501,191.014,193.031,196.89,202.254,206.379,210.115,212.132,215.937,218.813,220.831,223.708,227.558,231.683,234.089,237.99,240.867,244.132,246.538,248.555,252.679,256.804,258.821,262.086,265.994,269.73,272.995,275.013,279.138,283.001,285.877,289.143,292.408,295.673,299.797,302.203,306.413" y="279.837" svg_rhmargin="309.29" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[32] Xie F, Zhang AB, Ouyang JL. Analysis of retinoic acid receptor</text>
  <text x="309.262" y="279.837" svg_rhmargin="313.85" style="fill:#171615;font-family:LJLAKN+AdvP7DA6;font-size:7.47px;font-style:NORMAL;font-weight:normal;">b</text>
  <text x="313.909" y="281.09000000000003" svg_rhmargin="317.002" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:4.98px;font-style:NORMAL;font-weight:normal;">2</text>
  <text x="88.441,92.565,95.442,99.566,105.708,109.833,112.239,115.504,118.381,121.037,123.054,127.179,129.823,133.948,135.965,140.09,144.214,148.339,150.969,155.094,157.111,160.847,163.724,169.866,173.602,176.252,180.378,182.784,185.437,189.562,193.298,195.704,197.721,200.986,205.111,207.517,210.394,213.101,218.854,220.872,223.278,227.403,230.051,234.175,237.052,240.317,244.053,246.93,249.336,251.99,255.255,258.991,263.115,266.38,269.645,272.522,274.539,277.216,280.093,282.715,288.94,293.064,297.189,300.454,302.471,305.108,307.514,311.638,314.515" y="288.8" svg_rhmargin="316.921" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">promoter in blood plasma of patients with breast cancer. J Hubei Inst</text>
  <text x="88.441,95.913,99.179,103.304,105.79,109.915,114.04,118.165,122.29,124.309,128.434,132.559,134.649,138.774,142.899" y="297.757" svg_rhmargin="147.023" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Med 2011;30:371</text>
  <text x="147.004" y="297.757" svg_rhmargin="150.74" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="150.746,154.871" y="297.757" svg_rhmargin="156.888" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">3.</text>
  <text x="72.057,74.463,78.587,82.712,85.11800000000001,88.44,93.805,97.541,101.665,105.79,109.526,113.262,116.274,120.787,126.152,128.169,131.183,136.085,138.962,142.697,145.963,148.368,152.493,156.229,159.105,163.23,166.966,170.702,174.438,177.441,183.194,188.559,190.576,193.597,197.333,200.598,203.475,207.21,210.476,213.741,217.477,221.213,224.266,230.019,232.425,234.442,237.417,240.683,243.089,246.091,249.827,251.845,253.862,256.863,264.335,267.6,270.006,274.13,277.866,279.883,283.619,286.113,288.131,292.255,296.38,298.785,302.91,306.646,309.522,312.788" y="306.714" svg_rhmargin="316.912" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[33] Rykova EY, Tsvetovskaya GA, Sergeeva GI, et al. Methylation-based</text>
  <text x="88.441,92.177,96.301,100.037,102.055,105.79,108.667,110.684,113.56099999999999,115.765,119.889,122.295,124.495,127.76,129.777,132.654,135.919,140.043,142.061,145.797,148.203,150.22,154.344,158.07999999999998,160.378,166.131,172.273,177.638,179.822,182.228,186.353,189.23000000000002,191.444,195.569,198.445,201.71,205.446,208.394,210.8,212.986,215.392,219.516,225.658,229.783,232.66,234.868,237.745,241.01,243.886,247.152,250.417,254.541,256.559,260.683,264.419,266.436,268.711,274.076,278.2,282.325,284.527,290.669,292.861,298.226,300.458,305.822,309.088,312.824" y="315.672" svg_rhmargin="316.948" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">analysis of circulating DNA for breast tumor screening. Ann N Y Acad</text>
  <text x="88.441,92.178,95.443,97.46,99.95,104.076,108.201,112.326,116.451,118.469,122.595,126.72,130.845,134.97,136.988,141.113,145.239" y="324.686" svg_rhmargin="149.363" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Sci 2008;1137:232</text>
  <text x="149.442" y="324.686" svg_rhmargin="153.178" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="153.184,157.309" y="324.686" svg_rhmargin="159.326" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="72.057,74.463,78.587,82.712,85.11800000000001,88.44,94.664,98.789,102.913,107.037,110.302,111.909,119.381,125.523,127.53999999999999,129.199,133.323,136.588,140.713,144.44899999999998,146.092,152.234,154.251,155.899,160.801,164.925,169.05,171.926,175.19099999999997,176.817,180.942,182.959,184.64,187.906,190.312,191.897,195.633,197.65,199.667,201.308,207.061,210.326,212.732,215.997,219.262,221.668,223.686,227.81,231.935,233.62,237.745,240.151,241.785,245.521,249.645,252.91,255.787,258.734,262.47,266.595,269.00100000000003,270.639,276.782,280.047,282.453,286.577,290.313,292.331,296.067,298.472,300.49,304.614,308.739,310.435,314.559" y="333.643" svg_rhmargin="316.965" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[34] Hoque MO, Feng Q, Toure P, et al. Detection of aberrant methylation of</text>
  <text x="88.441,90.847,94.971,99.096,101.973,103.407,107.143,110.408,114.532,117.798,120.675,122.171,124.188,128.313,129.711,133.835,135.852,139.588,142.465,148.607,152.343,153.86,159.614,165.755,171.12,172.567,174.973,179.098,181.97500000000002,183.452,185.857,189.982,193.24699999999999,194.676,198.801,202.066,204.472,207.737,211.002,213.408,215.426,219.55,223.675,225.175,229.299,231.705,233.168,237.293,240.169,243.434,247.17,250.047,252.453,253.916,257.181,260.917,265.041,268.307,271.572,274.448,276.465,277.952,280.829,282.261,287.626,289.644,291.661,295.786,297.228,303.369,307.494,310.759,314.883" y="342.6" svg_rhmargin="316.9" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">four genes in plasma DNA for the detection of breast cancer. J Clin Oncol</text>
  <text x="88.441,92.566,96.691,100.816,104.942,106.96,111.085,115.21,117.228,121.353,125.479,129.604" y="351.557" svg_rhmargin="133.728" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2006;24:4262</text>
  <text x="133.795" y="351.557" svg_rhmargin="137.531" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="137.48,141.604" y="351.557" svg_rhmargin="143.621" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="72.057,74.463,78.587,82.712,85.11800000000001,88.44,92.176,96.301,100.036,104.161,107.037,109.443,112.32,116.444,120.18,123.91600000000001,127.045,131.946,136.459,138.476,141.614,146.979,150.715,154.839,158.964,162.699,166.435,169.618,174.131,179.496,181.513,184.641,189.543,193.278,199.42,203.545,207.669,211.405,213.495,216.76,220.885,223.983,227.719,233.861,235.878,239.006,242.271,244.677,247.85,251.585,253.603,255.62,258.734,264.098,267.364,269.381,271.398,273.804,276.21,279.087,282.352,285.61699999999996,288.835,292.571,296.696,300.821,303.915,307.18,310.445,312.463,314.48" y="360.514" svg_rhmargin="316.886" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[35] Skvortsova TE, Rykova EY, Tamkovich SN, et al. Cell-free and cell-</text>
  <text x="88.441,92.565,96.69,100.814,104.939,109.064,112.704,115.969,117.987,120.863,124.128,128.253,130.27,134.006,136.412,138.429,142.554,146.29,150.005,155.758,161.9,167.26500000000001,170.924,172.941,177.066,180.674,184.799,187.675,190.941,194.676,197.553,199.959,203.633,206.039,210.163,216.305,220.43,224.554,227.431,230.307,232.32399999999998,236.002,241.756,247.897,253.262,256.921,261.045,265.17,268.906,273.03,275.436" y="369.472" svg_rhmargin="277.453" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">bound circulating DNA in breast tumours: DNA quanti</text>
  <text x="277.511" y="369.472" svg_rhmargin="281.635" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="281.65,284.915,288.651,291.057,293.074,297.199,301.324,304.949,308.685,312.809" y="369.472" svg_rhmargin="316.933" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cation and</text>
  <text x="88.442,92.178,96.302,100.038,102.055,105.791,108.668,110.685,113.562,117.636,121.761,124.167,128.237,130.643,134.768,140.909,145.034,149.158,152.035,154.441,157.317,160.583,162.703,166.439,168.845,172.11,176.235,180.277,184.013,187.278,191.402,194.66699999999997,198.758,204.899,208.165,210.57,214.695,218.431,220.448,224.184,226.59,228.607,232.732,236.856,238.873,243.031,247.545,250.422,254.483,257.36,261.4,266.764,270.5,274.625,277.89,281.155,284.032,288.1,292.225,296.349,300.473,304.598,306.694,310.819,314.943" y="378.486" svg_rhmargin="316.96" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">analysis of tumour-related gene methylation. Br J Cancer 2006;94:</text>
  <text x="88.442,92.567,96.692,100.817" y="387.443" svg_rhmargin="104.941" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">1492</text>
  <text x="104.939" y="387.443" svg_rhmargin="108.675" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="108.681,112.806" y="387.443" svg_rhmargin="114.823" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="72.058,74.463,78.588,82.712,85.11800000000001,88.441,92.565,94.583,97.459,101.584,105.708,108.973,113.098,116.834,120.958,124.694,128.81900000000002,130.277,134.013,136.03,137.42,142.322,146.057,148.075,151.34,155.464,159.2,163.325,164.744,168.868,174.233,176.25,177.668,185.14,188.405,192.53,196.716,198.733,202.857,206.982,211.106,213.983,215.366,219.49,221.507,222.962,226.228,228.63400000000001,230.049,233.785,235.802,237.819,239.232,244.597,247.474,250.35,254.475,257.74,259.757,263.493,265.899,267.917,272.041,276.166,277.61,281.735,284.141,285.547,287.953,292.077,294.095,297.831,300.237,303.502,304.935,308.671,312.795" y="396.4" svg_rhmargin="316.919" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[36] Pirouzpanah S, Taleban FA, Mehdipour P, et al. Association of folate and</text>
  <text x="88.442,92.566,94.972,99.096,102.362,105.23899999999999,108.737,112.861,116.985,120.251,122.657,125.922,129.658,132.534,136.659,140.783,144.908,148.419,151.295,154.56,156.578,160.314,162.72,165.985,170.11,173.645,177.769,181.894,184.3,187.176,189.194,192.459,196.583,198.989,201.866,205.39,211.144,213.161,215.567,219.692,223.191,227.316,231.051,235.176,238.441,241.388,247.531,250.796,253.202,257.326,261.062,263.079,266.815,269.221,271.239,275.363,279.488,282.998,285.874,288.28,292.016,294.422,298.546,301.423,304.936,308.672,312.797" y="405.357" svg_rhmargin="316.921" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">other one-carbon related nutrients with hypermethylation status and</text>
  <text x="88.442,91.707,95.831,99.956,102.832,106.098,108.974,111.851,113.868,117.993,122.118,125.686,129.81,132.216,135.719,141.084,146.449,151.814,156.327,158.344,161.91,166.423,171.787,177.152,182.517,186.641,188.658,192.181,195.917,200.041,204.166,207.714,213.079,218.443,222.179,225.915,230.04,234.164,239.529,243.088,246.824,250.089,254.213,257.478,260.355,263.892,265.91,270.035,273.53,277.654,280.531,283.796,287.532,290.48,292.886,296.376,299.641,303.377,307.501,310.766,314.032" y="414.314" svg_rhmargin="316.909" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">expression of RARB, BRCA1, and RASSF1A genes in breast cancer</text>
  <text x="88.442,92.566,96.302,98.708,100.725,103.991,108.115,110.521,113.397,115.414,117.976,120.853,123.305,130.777,134.901,136.918,139.461,146.933,150.198,154.323,156.809,159.215,163.728,166.993,169.869,171.887,174.293,176.82,180.944,185.068,189.193,193.317,195.335,199.459,203.584,205.673,209.798,213.922" y="423.271" svg_rhmargin="218.046" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">patients. J Mol Med (Berl) 2015;93:917</text>
  <text x="218.041" y="423.271" svg_rhmargin="221.777" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="221.783,225.908,230.033" y="423.271" svg_rhmargin="232.05" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="72.058,74.463,78.588,82.712,85.11800000000001,88.441,93.342,97.078,101.203,105.164,112.636,118.86,120.877,124.835,132.307,136.043,138.92,140.937,144.673,148.798,152.783,158.148,160.165,164.121,170.262,172.28,175.545,179.483,182.36,184.377,188.327,191.592,193.99800000000002,197.964,201.7,203.717,205.734,209.699,214.212,218.337,222.461,226.197,230.164,236.306,240.042,242.919,245.79600000000002,249.779,253.515,257.639,261.764,265.709,271.462,277.604,282.969,286.967,291.092,293.968,298.093,304.235,308.359,310.765,314.03" y="432.229" svg_rhmargin="316.907" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[37] Tao MH, Marian C, Nie J, et al. Body mass and DNA promoter</text>
  <text x="88.442,94.584,97.849,100.255,104.379,108.115,110.132,113.868,116.274,118.292,122.416,126.541,128.917,130.935,135.06,137.421,141.545,144.422,147.687,151.423,154.3,156.70600000000002,159.076,161.482,165.606,171.748,175.872,178.749,181.626,184.019,186.036,190.161,192.466,194.872,198.996,202.261,204.654,212.126,215.391,218.268,220.674,223.939,226.816,230.941,233.282,239.424,242.689,248.442,250.799,256.164,260.289,263.165,267.29,269.677,274.19,278.314,282.439,286.563,289.44,293.564,296.441,299.706,302.583,304.937,308.673,312.797" y="441.243" svg_rhmargin="316.921" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">methylation in breast tumors in the Western New York Exposures and</text>
  <text x="88.442,92.955,95.831,99.096,102.832,105.709,108.11500000000001,110.607,115.972,119.707,123.832,127.097,130.362,133.239,135.776,139.512,141.918,146.043,150.167,153.903,155.92,158.452,163.816,169.958,172.455,175.33200000000002,177.84,183.206,185.223,187.241,191.366,193.884,200.026,204.151,206.557,209.434,211.968,216.093,220.217,224.342,228.466,230.484,234.608,238.732,240.75,244.874,248.999" y="450.2" svg_rhmargin="253.123" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Breast Cancer Study. Am J Clin Nutr 2011;94:831</text>
  <text x="253.19" y="450.2" svg_rhmargin="256.926" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="256.932,261.057" y="450.2" svg_rhmargin="263.074" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="72.058,74.463,78.588,82.712,85.11800000000001,88.441,93.806,97.542,101.666,105.402,108.566,114.707,116.72399999999999,119.96,123.696,127.432,131.556,135.681,138.557,142.293,144.31,147.511,152.412,154.429,157.658,163.023,167.147,170.024,174.148,176.166,182.308,186.432,189.309,193.045,196.263,202.016,204.033,207.204,210.469,212.875,216.104,219.84,221.857,223.874,227.045,233.269,237.005,241.129,244.395,247.339,253.481,256.746,259.152,263.277,267.012,269.03,272.766,275.172,277.189,281.314,285.439,288.665,292.789,296.914,300.179,303.056,306.295,310.42,314.544" y="459.157" svg_rhmargin="316.95" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[38] Yang Q, Sakurai T, Yoshimura G, et al. Hypermethylation does not</text>
  <text x="88.442,92.178,95.443,98.708,102.832,106.957,111.081,113.48700000000001,115.369,117.775,121.899,124.776,126.706,129.112,133.237,136.50199999999998,138.385,140.791,143.667,146.932,151.057,155.181,158.447,162.571,164.977,166.899,168.916,173.04,175.917,178.794,180.73,184.855,187.261,189.12,191.526,195.651,198.916,200.855,203.732,206.997,209.403,211.42,215.545,219.669,221.686,224.951,226.875,230.611,233.876,235.893,240.018,241.898,244.774,248.039,251.305,254.57,258.694,261.1,265.225,268.10200000000003,270.015,274.14,277.405,279.879,283.615,287.74,289.573,291.59,295.715,297.623,301.747,304.624,307.889,311.625,314.502" y="468.114" svg_rhmargin="316.908" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">account for the frequent loss of the retinoic acid receptor beta2 in breast</text>
  <text x="88.442,91.707,95.443,98.319,101.585,103.602,107.726,111.851,117.993,121.729,123.746,126.31,131.674,135.799,138.205,140.222,143.487,147.223,151.348,154.613,157.878,160.755,163.27,168.635,171.9,174.77700000000002,177.329,181.454,185.579,189.703,193.828,195.845,199.97,204.094,206.111,210.236,214.36,218.485" y="477.071" svg_rhmargin="222.609" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoma. Anticancer Res 2001;21:1829</text>
  <text x="222.633" y="477.071" svg_rhmargin="226.369" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="226.375,230.5,234.625" y="477.071" svg_rhmargin="236.642" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">33.</text>
  <text x="72.058,74.463,78.588,82.712,85.11800000000001,88.441,95.913,99.649,102.525,105.79,109.056,111.932,115.197,117.352,123.106,130.577,132.594,134.756,140.98,145.104,149.229,153.354,155.504,161.257,164.993,167.01,169.166,174.531,178.655,182.78,186.904,190.64,192.806,198.17,203.535,205.552,207.715,210.98,213.386,215.482,219.218,221.235,223.252,225.403,231.156,237.298,242.663,244.847,250.989,254.254,256.66,260.785,264.521,266.538,270.274,272.68,274.697,278.822,282.947,285.152,287.17,291.294,295.419,298.684,302.809,304.937,308.673,312.797" y="486.029" svg_rhmargin="316.921" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[39] Marzese DM, Hoon DS, Chong KK, et al. DNA methylation index and</text>
  <text x="88.442,94.584,97.849,100.255,104.379,108.115,110.132,113.868,116.274,118.292,122.416,126.541,130.845,134.969,137.846" y="495.043" svg_rhmargin="141.97" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">methylation pro</text>
  <text x="141.959" y="495.043" svg_rhmargin="146.083" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="146.098,148.115,151.38,155.622,159.747,162.15300000000002,166.45,168.468,172.592,176.328,180.064,182.941,184.958,188.694,191.95899999999997,196.212,200.336,204.461,207.726,210.132,213.868,215.885,220.134,224.259,227.135,230.401,234.137,237.084,239.49,243.717,246.123,250.247,256.389,260.514,263.39,266.267,268.284,272.572,275.449,279.715,287.187,291.312,293.329,297.572,303.325,305.343,309.079,312.815" y="495.043" svg_rhmargin="316.939" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">le of invasive ductal breast tumors. J Mol Diagn</text>
  <text x="88.442,92.567,96.692,100.817,104.942,106.961,111.086,115.211,117.229,121.354,125.479" y="504.0" svg_rhmargin="129.603" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2012;14:613</text>
  <text x="129.657" y="504.0" svg_rhmargin="133.393" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="133.399,137.524,141.649" y="504.0" svg_rhmargin="143.666" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">22.</text>
  <text x="72.058,74.463,78.588,82.712,85.11800000000001,88.441,93.806,97.93,102.055,104.654,110.019,116.243,118.25999999999999,120.867,124.603,128.727,131.993,136.118,138.724,141.601,143.618,146.264,152.017,155.753,161.895,168.037,172.161,176.286,178.916,186.388,192.141,194.158,196.773,200.038,202.44400000000002,205.05,208.786,210.803,212.82,215.423,219.548,222.425,226.549,230.285,234.471,238.595,241.472,243.878,245.895,249.16,251.761,254.638,256.655,260.391,264.515" y="512.957" svg_rhmargin="266.532" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[40] Cho YH, Shen J, Gammon MD, et al. Prognostic signi</text>
  <text x="266.57" y="512.957" svg_rhmargin="270.694" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="270.709,273.974,277.71,281.834,285.099,288.364,291.004,295.128,297.534,300.13,303.866,307.132,311.256,314.521" y="512.957" svg_rhmargin="316.927" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cance of gene-</text>
  <text x="88.442,91.319,95.444,98.709,101.974" y="521.914" svg_rhmargin="103.991" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">speci</text>
  <text x="104.033" y="521.914" svg_rhmargin="108.157" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="108.115,111.38,115.201,119.326,122.203,126.327,132.469,136.594,139.0,142.265,145.142,148.931,153.056,156.792,160.916,164.181,167.128,173.27,176.535,178.941,183.065,186.801,188.819,192.555,194.96,196.978,201.102,205.227,209.078,211.095,215.22,218.999,223.124,226.001,229.266,233.002,235.878,238.284,242.072,245.337,249.073,253.197,256.527,259.793,262.67,266.448,270.574,274.309,276.715,278.733,281.998,286.122,288.528,291.405,293.42199999999997,297.231,301.744,304.62,307.885,311.621,314.498" y="521.914" svg_rhmargin="316.904" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">c promoter hypermethylation in breast cancer patients. Breast</text>
  <text x="88.442,93.807,97.543,101.668,104.933,108.198,111.07499999999999,113.612,118.977,122.242,125.119,127.614,132.516,135.393,138.658,142.394,144.8,147.343,151.467,155.592,159.716,163.84,165.858,169.982,174.107,178.231,180.248,184.373,188.497" y="530.871" svg_rhmargin="192.621" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cancer Res Treat 2012;131:197</text>
  <text x="192.643" y="530.871" svg_rhmargin="196.379" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="196.385,200.511,204.636,208.761" y="530.871" svg_rhmargin="210.778" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">205.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,93.807,97.931,102.056,104.032,109.396,111.413,113.442,117.955,119.972,121.946,125.682,127.699,129.712,137.184,140.92,145.044,148.78,150.801,156.942,158.959,160.948,164.213,166.619,168.601,172.337,174.355,176.37199999999999,178.409,184.551,188.675,192.411,196.536,198.941,200.959,203.365,207.101,209.507,211.524,215.26,218.52499999999998,220.585,224.321,228.445,232.57,234.587,237.852,241.977,244.853,247.73,250.995,253.013,256.749,259.154,261.172,265.296,269.421,271.434,275.17,279.295,283.031,285.048,288.784,291.728,293.746,296.623,298.588,302.713,305.119,307.149,309.555,313.679" y="539.828" svg_rhmargin="316.944" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[41] Zhu Y, Li S, Wang Q, et al. Quantitative and correlation analysis of the</text>
  <text x="88.442,94.196,100.338,105.70299999999999,109.701,115.843,119.108,121.514,125.639,129.375,131.392,135.128,137.534,139.551,143.676,147.801,151.821,155.556,159.681,163.806,167.75,171.016,175.14,179.264,182.206,185.471,188.348,191.225,193.242,197.366,201.491,205.449,209.574,211.98000000000002,215.994,221.747,227.112,231.236,236.601,240.597,242.614,246.739,250.688,254.813,257.689,260.954,264.69,267.567,269.973,273.987,277.253,280.989,285.113,288.378,291.643,294.52,296.537,300.518,304.642,307.907,311.172,314.049" y="548.842" svg_rhmargin="316.926" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">DNA methylation and expression of DAPK in breast cancer. PeerJ</text>
  <text x="88.442,92.567,96.691,100.816,104.94,106.958,111.082,113.099,116.365,120.489,124.613,128.738,132.862" y="557.8" svg_rhmargin="134.879" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2017;5:e3084.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,91.318,95.443,99.567,103.303,105.675,110.188,113.065,115.082,117.467,122.832,124.85,130.992,133.397,135.803,139.539,141.55599999999998,143.942,148.454,151.72,154.98499999999999,157.377,161.89,167.255,169.272,171.663,174.928,177.334,179.713,183.449,185.466,187.483,189.86,195.225,199.349,205.491,209.616,213.352,216.228,218.246,221.122,225.247,229.372,231.809,235.934,238.34,240.71,246.851,250.117,252.522,256.647,260.383,262.4,266.136,268.542,270.559,274.779,278.904,281.242,285.367,288.244" y="566.7570000000001" svg_rhmargin="292.368" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[42] Jung EJ, Kim IS, Lee EY, et al. Comparison of methylation pro</text>
  <text x="292.423" y="566.7570000000001" svg_rhmargin="296.547" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="296.504,298.522,300.539,304.664,308.4,310.791,312.808" y="566.7570000000001" svg_rhmargin="316.932" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ling in</text>
  <text x="88.443,91.708,95.444,99.568,102.833,106.098,108.975,113.099,117.224,120.101,122.228,125.964,130.089,134.214,136.287,138.693,142.818,146.083,148.1,150.977,153.124,156.39,160.514,163.391,166.267,169.532,172.409,176.534,180.658,184.782,188.907,190.924,195.13,198.86599999999999,200.913,205.037,209.161,212.038,218.26,221.996,224.013,226.083,228.489,230.506,233.383,236.259,240.384,243.649,246.526,248.645,251.051,253.927,258.052,264.194,266.332,271.697,275.821,278.698,281.963,285.699,289.824,291.955,296.079,299.815,302.221,304.239,307.504,311.628,314.034" y="575.7139999999999" svg_rhmargin="316.911" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancerous and their corresponding normal tissues from Korean patients</text>
  <text x="88.443,94.196,96.213,98.619,102.744,105.223,109.347,112.224,115.489,119.225,122.172,124.578,127.048,130.313,134.049,138.173,141.439,144.704,147.58,149.597,152.161,157.525,161.65,165.775,168.26,172.774,176.51,180.635,183.17,190.642,193.907,198.032,200.517,204.642,208.767,212.891,217.016,219.033,223.158,227.282,229.299,233.424,237.548" y="584.671" svg_rhmargin="241.672" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">with breast cancer. Ann Lab Med 2013;33:431</text>
  <text x="241.739" y="584.671" svg_rhmargin="245.475" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="245.481,249.605,253.73" y="584.671" svg_rhmargin="255.747" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">40.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,91.318,93.336,97.46,101.196,103.634,107.759,109.776,112.252,117.617,121.741,125.866,127.883,132.008,135.744,138.215,145.687,147.704,150.177,155.542,159.666,163.79,167.52599999999998,169.961,175.326,177.343,179.826,183.091,185.497,187.933,191.668,193.686,195.703,198.194,203.558,207.683,213.43599999999998,215.881,217.898,220.775,222.792,226.528,230.733,234.858,237.31,243.452,246.718,249.124,253.248,256.984,259.001,262.737,265.143,269.267,272.144,274.611,278.736,282.86,286.125,290.314,294.439,296.845,300.581,304.705,307.96999999999997,310.439,314.564" y="593.6279999999999" svg_rhmargin="316.97" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[43] Jing F, Yuping W, Yong C, et al. CpG island methylator phenotype of</text>
  <text x="88.443,94.584,98.709,100.726,103.132,105.149,108.885,112.151,116.275,119.54,125.12,127.137,131.262,136.855,139.732,142.997,145.874,149.998,156.14,161.742,165.867,168.273,173.818,176.694,180.819,184.943,187.82,191.556,195.68,197.697,200.962,206.584,210.708,213.585,216.85,220.586,223.462,225.868,231.413,234.678,238.414,241.291,244.556,246.574,250.698,254.822,261.061,264.797,266.814,272.343,277.245,281.37,287.511,291.636,295.76,298.637,304.259,308.772,310.79,314.914" y="602.586" svg_rhmargin="316.931" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">multigene in serum of sporadic breast carcinoma. Tumour Biol</text>
  <text x="88.443,92.568,96.693,100.818,104.943,106.961,111.087,115.212,117.23,121.355,125.48" y="611.6" svg_rhmargin="129.604" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2010;31:321</text>
  <text x="129.658" y="611.6" svg_rhmargin="133.394" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="133.4,137.525,141.65" y="611.6" svg_rhmargin="143.667" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">31.</text>
  <text x="72.058,74.464,78.589,82.713,85.119,88.442,93.807,97.931,104.073,107.338,111.463,115.879,118.285,123.65,125.667,130.108,134.233,138.357,141.234,144.499,148.624,153.011,158.376,165.847,167.864,172.285,178.509,182.245,188.387,191.729,195.854,200.233,205.135,207.152,211.571,214.836,217.24200000000002,221.662,225.398,227.415,229.432,233.85,238.363,242.487,244.505,248.24,251.506,255.63,258.895,261.301,263.319,266.584,271.038,274.774,276.791,279.197,282.462,285.339,289.075,291.48,293.498,297.622,301.747,304.624,309.076,313.2" y="620.557" svg_rhmargin="316.936" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[44] Ahmed IA, Pusch CM, Hamed T, et al. Epigenetic alterations by</text>
  <text x="88.443,94.584,97.85,100.255,104.38,108.116,110.133,113.869,116.275,118.292,122.417,126.542,128.521,132.646,135.052,136.968,142.333,147.698,151.434,155.169,159.294,163.418,168.78300000000002,170.698,174.434,178.558,182.683,184.587,190.34,195.705,199.829,205.278,209.403,211.288,215.412,218.289,222.413,228.555,232.68,235.086,238.351,241.228,243.204,246.08,249.346,253.47,257.594,260.86,264.984,268.249,271.514,274.391,276.31,278.327,282.452,284.417,290.558,294.294,300.436,306.578,310.314,313.19" y="629.514" svg_rhmargin="316.926" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">methylation of RASSF1A and DAPK1 promoter sequences in mammary</text>
  <text x="88.443,91.708,95.444,98.32,101.585,103.603,107.727,111.852,117.993,121.729,127.841,131.966,135.231,137.637,140.902,144.167,146.573,149.838,153.963,160.097,162.114,166.239,172.286,175.551,179.675,182.081,184.958,188.694,191.959,195.301,197.319,199.336,203.46,205.478,209.214,212.091,218.204,220.61,224.734,230.876,235.0,237.877,243.94,249.694,255.836,261.2,263.217,269.337,274.702,278.438,282.562,285.827,289.092,291.969,298.078,303.831,307.097,311.221,314.486" y="638.471" svg_rhmargin="316.892" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoma detected in extracellular tumor DNA. Cancer Genet</text>
  <text x="88.443,93.808,97.545,99.951,104.077,107.813,111.079,115.204,118.47,120.876,123.425,127.55,131.675,135.8,139.925,141.944,146.069,150.194,154.319,156.337,160.462" y="647.428" svg_rhmargin="164.586" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cytogenet 2010;199:96</text>
  <text x="164.638" y="647.428" svg_rhmargin="168.374" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="168.38,172.505,176.63,180.755" y="647.428" svg_rhmargin="182.772" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">100.</text>
  <text x="72.059,74.465,78.589,82.714,85.12,88.443,93.807,97.543,101.668,103.692,107.817,111.082,113.95899999999999,115.994,121.359,125.483,131.237,134.502,137.378,141.11399999999998,143.148,145.554,147.571,149.61,154.123,158.248,161.984,164.001,167.266,169.338,174.703,176.72,178.749,182.485,186.221,189.486,193.61,196.487,199.364,203.488,207.613,209.644,215.01,217.027,219.056,222.321,224.727,226.766,230.502,232.519,234.536,236.573,242.715,246.839,250.575,254.7,257.106,259.123,261.529,265.265,267.671,269.688,273.424,276.68899999999996,278.806,284.948,288.213,290.619,294.743,298.479,300.497,304.233,306.638,308.656,312.78" y="656.386" svg_rhmargin="316.904" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[45] Van der Auwera I, Bovie C, Svensson C, et al. Quantitative methylation</text>
  <text x="88.443,92.568,95.446" y="665.4" svg_rhmargin="99.57" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">pro</text>
  <text x="99.555" y="665.4" svg_rhmargin="103.679" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="103.694,105.711,107.729,111.853,115.589,118.717,120.734,124.859,128.014,130.42,134.544,140.686,144.811,147.68800000000002,150.86,154.596,158.72,162.845,165.939,172.082,175.818,178.224,181.489,185.613,188.955,193.08,196.212,202.355,206.479,209.356,213.48,217.605,221.729,223.746,227.871,231.607,233.624,236.889,240.625,242.643,244.66,248.396,251.597,255.721,259.846,262.722,268.864,272.6,274.617,277.787,280.193,282.21,285.087,287.964,292.088,295.353,298.23,301.369,303.775,306.652,310.776" y="665.4" svg_rhmargin="316.918" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ling in tumor and matched morphologically normal tissues from</text>
  <text svg_rhmargin="246.95" x="88.444,92.568,95.445,98.71,102.446,105.323,107.729,110.212,113.478,117.213,121.338,124.668,127.933,130.81,133.285,137.41,141.146,143.552,145.569,148.834,152.959,155.364,158.241,160.258,162.82,167.333,174.805,180.17000000000002,182.661,188.026,191.762,195.886,199.151,202.417,205.294,207.831,211.955,216.08,220.204,224.328,226.346,230.47,234.595,236.685,240.809,244.933,246.95" y="37.75599999999997" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast cancer patients. BMC Cancer 2010;10:97. </text>
  <text x="332.052,334.458,338.583,342.707,345.113,348.436,353.8,357.536,361.661,363.288,367.413,370.678,373.555,375.194,380.558,384.683,390.436,393.701,396.578,400.31399999999996,401.951,404.357,406.374,408.017,412.53,416.654,420.39,422.407,425.67199999999997,427.291,432.656,434.673,436.305,440.041,443.777,447.042,451.166,454.043,456.919,461.044,465.169,466.803,472.168,474.185,475.817,479.082,481.488,483.13,486.866,488.884,490.901,492.541,498.683,502.807,506.543,510.668,513.074,515.091,517.497,521.233,523.639,525.656,529.392,532.657,534.321,538.057,540.933,543.81,547.075,549.952,552.828,558.97,562.235,566.36,568.766,570.431,574.556" y="37.75599999999997" svg_rhmargin="576.962" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[46] Van der Auwera I, Bovie C, Svensson C, et al. Quantitative assessment of</text>
  <text x="348.436,354.19,360.332,365.697,370.035,374.16,377.896,382.02,385.285,388.162,394.304,397.569,399.975,404.099,407.835,409.852,413.588,415.994,418.012,422.244,426.369,430.635,432.653,436.778,441.067,443.472,447.597,450.86199999999997,455.125,457.143" y="46.712999999999965" svg_rhmargin="461.267" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">DNA hypermethylation in the in</text>
  <text x="461.311" y="46.712999999999965" svg_rhmargin="465.435" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="465.45,469.186,475.328,481.47,485.206,487.611,491.736,494.613,498.349,502.695,506.431,510.555,514.6800000000001,518.965,523.09,527.214,531.339,533.745,535.762" y="46.712999999999965" svg_rhmargin="539.886" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory and non-in</text>
  <text x="539.887" y="46.712999999999965" svg_rhmargin="544.011" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="544.026,547.762,553.905,560.048,563.784,566.191,570.316,573.281" y="46.712999999999965" svg_rhmargin="577.017" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory</text>
  <text x="348.436,352.561,355.438,358.703,362.439,365.315,367.721,370.262,373.527,377.263,381.387,384.652,387.917,390.794,393.334,397.458,401.583,404.848,408.972,413.097,415.502,419.238,423.363,426.628,429.505,431.522,434.036,439.4,443.136,447.261,450.526,453.791,456.668,459.205,463.718,465.735,469.86,471.877,474.397,479.299,483.423,486.688,489.565,492.085,496.209,500.333,504.458,508.582,510.6,514.724,516.742,520.939,525.064,529.188" y="55.66999999999996" svg_rhmargin="533.312" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast cancer phenotypes. Cancer Biol Ther 2009;8:2252</text>
  <text x="533.311" y="55.66999999999996" svg_rhmargin="537.047" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="537.053,541.178" y="55.66999999999996" svg_rhmargin="543.195" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,351.313,354.578,357.455,361.579,365.704,367.721,373.947,378.072,382.847,388.212,390.229,395.036,402.508,406.633,410.757,413.233,416.498,418.516,421.392,425.517,430.297,434.421,436.438,441.294,447.518,450.784,454.908,457.785,459.802,463.926,468.051,471.316,476.158,481.522,483.539,488.346,491.612,494.01800000000003,498.835,502.571,504.588,506.605,511.42,517.562,521.686,525.422,529.547,531.953,533.97,536.376,540.112,542.518,544.535,548.271,551.536,556.431,560.556,564.292,568.416,571.681,574.558" y="64.62699999999995" svg_rhmargin="576.964" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[47] Jeronimo C, Monteiro P, Henrique R, et al. Quantitative hyper-</text>
  <text x="348.437,354.579,357.844,360.25,364.375,368.11,370.128,373.947,376.353,378.37,382.494,386.619,388.006,392.13,394.536,395.942,399.678,401.045,403.921,410.063,413.799,415.816,417.83299999999997,419.241,423.366,427.102,431.226,434.491,436.508,437.892,442.016,444.422,445.828,449.564,452.829,456.954,460.219,463.096,464.535,468.271,472.396,476.132,482.273,485.539,489.663,492.069,494.946,496.338,498.743,502.868,506.133,507.562,511.687,513.704,517.44,521.176,525.3,529.425,532.302,534.708,536.725,539.99,541.405,545.141,548.406,551.672,555.796,558.673,562.409,565.674,569.41,570.826,572.844" y="73.58500000000004" svg_rhmargin="576.968" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">methylation of a small panel of genes augments the diagnostic accuracy in</text>
  <text x="348.437" y="82.54200000000003" svg_rhmargin="352.561" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="352.576,356.7,359.965,362.371,366.496,369.761,373.026,377.151,379.168,382.433,384.661,388.397,391.274,395.398,397.416,400.364,404.1,406.506,409.77099999999996,411.986,417.739,421.475,424.351,428.476,430.493,434.618,438.353,441.23,443.448,447.572,449.978,452.178,456.302,459.179,462.444,466.18,469.057,471.463,473.72,475.737,479.002,481.879,483.896,488.021,492.145,495.022,497.039,499.286,503.799,506.676,509.941,513.677,516.553,518.959,521.168,526.533,530.269,534.393,537.658,540.923,543.8,546.054,551.419,554.684,557.5609999999999,559.773,564.676,567.552,570.817,574.553" y="82.54200000000003" svg_rhmargin="576.959" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ne-needle aspirate washings of breast lesions. Breast Cancer Res Treat</text>
  <text x="348.437,352.562,356.686,360.81,364.935,366.952,371.077,375.201,379.326,381.43,385.554" y="91.55600000000004" svg_rhmargin="389.678" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2008;109:27</text>
  <text x="389.652" y="91.55600000000004" svg_rhmargin="393.388" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="393.394,397.519,401.645" y="91.55600000000004" svg_rhmargin="403.662" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">34.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,352.172,356.297,360.421,364.157,366.563,371.076,374.812,378.077,380.692,383.569,385.586,388.175,395.647,399.771,403.896,406.302,411.667,415.791,419.527,423.652,426.269,430.394,432.411,434.999,440.365,443.63,446.895,449.301,456.773,460.897,464.633,468.758,471.337,476.702,478.719,481.314,484.579,486.985,489.591,493.326,495.344,497.361,499.965,507.437,510.702,513.108,517.232,520.968,522.986,526.722,529.128,531.145,535.269,539.394,542.028,546.152,549.888,552.294,554.7,557.965,560.842,564.966,567.843,570.429,574.553" y="100.51300000000003" svg_rhmargin="576.959" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[48] Sung-Bae J, Woo-Chan P, Kee-Whan K, et al. Methylation patterns of</text>
  <text x="348.437,351.702,355.438,359.563,362.828,366.093,368.97,371.453,375.188,378.065,380.942,385.066,388.331,390.349,394.085,396.491,399.756,403.881,405.862,409.598,412.863,416.988,420.253,423.13,425.08,427.097,431.222,433.187,437.311,440.188,443.453,447.189,450.066,452.472,454.445,457.71,461.446,465.57,468.835,472.101,474.977,476.99399999999997,478.934,481.81100000000004,483.753,488.267,491.143,494.408,498.144,501.021,503.427,505.408,510.773,514.509,518.633,521.899,525.164,528.0409999999999,530.011,534.135,538.26,542.384,546.509,548.526,552.65,556.775,558.792,562.917" y="109.47000000000003" svg_rhmargin="567.041" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer-associated genes in breast cancer. J Breast Cancer 2007;10:51</text>
  <text x="567.1" y="109.47000000000003" svg_rhmargin="570.836" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="570.842,574.966" y="109.47000000000003" svg_rhmargin="576.983" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,353.801,356.678,360.414,363.29,366.167,369.432,373.557,376.433,378.935,382.2,384.217,388.342,390.443,395.808,397.825,399.966,403.702,407.438,411.563,413.969,417.234,420.111,422.245,426.758,428.775,430.918,436.672,440.796,442.813,446.549,448.567,454.709,456.726,458.866,463.38,465.397,467.54,470.805,473.211,475.363,479.099,481.116,483.133,485.227,490.98,494.246,496.652,499.917,503.182,505.588,507.605,511.73,515.855,518.05,522.175,524.5809999999999,526.724,530.849,533.725,536.99,540.726,543.603,546.0089999999999,548.153,551.418,555.154,559.278,562.543,565.808,568.685,570.828,572.845" y="118.42700000000002" svg_rhmargin="576.969" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[49] Krassenstein R, Sauter E, Dulaimi E, et al. Detection of breast cancer in</text>
  <text svg_rhmargin="395.598" x="348.437,352.562,354.579,358.703,362.828,364.845,368.11,370.489,374.225,377.101,381.226,383.243,386.191,389.927,392.333,395.598" y="127.38499999999999" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">nipple aspirate </text>
  <text x="397.93" y="127.38499999999999" svg_rhmargin="402.054" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="402.068,406.193,408.21,412.335,414.71,418.834,422.57,424.914,430.279,434.403,440.156,442.544,444.562,447.439,449.456,453.192,457.316,461.441,463.803,467.927,471.663,475.787,479.052,481.999,488.141,491.406,493.812,497.937,501.673,503.69,507.426,509.832,511.849,515.974,520.098,522.115,524.515,529.88,531.898,533.915,538.04,540.445,545.81,549.546,553.67,556.936,560.201,563.078,565.445,570.81,574.075" y="127.38499999999999" svg_rhmargin="576.952" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">uid by CpG island hypermethylation. Clin Cancer Res</text>
  <text x="348.437,352.562,356.686,360.81,364.935,366.952,371.077,375.201,377.688,381.813,384.264,388.389,390.795,393.335,397.46,399.865,401.883,406.007" y="136.34199999999998" svg_rhmargin="410.131" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2004;10(1 Pt 1):28</text>
  <text x="410.175" y="136.34199999999998" svg_rhmargin="413.911" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="413.917,418.042,422.167" y="136.34199999999998" svg_rhmargin="424.184" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="332.053,334.459,338.583,342.708,345.11400000000003,348.436,352.172,356.297,360.033,364.158,365.613,373.085,375.102,376.498,381.862,383.88,388.005,389.479,395.704,397.721,399.117,403.631,405.64799999999997,407.111,409.988,412.005,413.404,416.669,419.075,420.547,424.283,426.3,428.317,429.73,435.484,438.749,441.155,444.42,447.685,450.091,452.108,456.233,460.358,461.872,465.997,468.403,469.809,473.545,477.669,480.935,483.811,486.688,490.424,494.548,496.954,498.436,504.578,507.843,510.249,514.374,518.11,520.127,523.863,526.269,528.286,532.411,536.536,538.005,542.13,544.536,545.942,549.678,551.102,553.978,555.996,560.12,562.526,566.262,569.527,573.652" y="145.356" svg_rhmargin="576.917" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[50] Shan M, Yin H, Li J, et al. Detection of aberrant methylation of a six-gene</text>
  <text x="348.437,352.562,356.298,360.422,363.687,365.704,368.391,370.409,374.534,377.122,379.999,383.264,386.141,390.265,396.407,399.061,404.814,410.956,416.321,419.016,421.422,425.546,428.423,431.034,435.159,437.176,440.912,444.648,448.772,452.897,455.773,457.791,460.668,463.347,467.471,469.877,472.53,476.655,479.531,482.796,486.532,489.409,491.815,494.469,497.734,501.47,505.594,508.86,512.125,515.001,517.018,519.695,525.837,529.961,533.227,537.351,539.757,543.493,546.37,550.106,553.371,555.7769999999999,558.413,562.538,566.662,570.787,574.911" y="154.313" svg_rhmargin="576.928" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">panel in serum DNA for diagnosis of breast cancer. Oncotarget 2016;</text>
  <text x="348.435,352.559,354.576,358.701,362.825,366.95,371.074" y="163.28200000000004" svg_rhmargin="375.198" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7:18485</text>
  <text x="375.25" y="163.28200000000004" svg_rhmargin="378.986" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="378.992,383.117,387.242" y="163.28200000000004" svg_rhmargin="389.259" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">94.</text>
  <text x="332.05,334.456,338.581,342.705,345.111,348.434,353.798,355.816,359.552,361.569,363.587,366.852,370.089,372.966,374.983,378.253,382.377,384.395,387.66,389.677,392.554,395.819,399.944,403.209,406.086,409.318,414.22,416.237,419.466,425.219,428.484,430.502,433.767,437.891,442.016,445.259,449.772,451.789,455.01,458.275,460.681,463.91,467.646,469.664,471.681,474.908,481.05,485.174,488.91,493.035,495.441,497.458,499.864,503.6,506.006,508.023,511.759,515.024,518.274,524.028,530.17,535.535,538.796,544.938,548.203,550.609,554.733,558.469,560.487,564.222,566.628,568.646,572.865" y="172.23900000000003" svg_rhmargin="576.989" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[51] Klajic J, Fleischer T, Dejeux E, et al. Quantitative DNA methylation</text>
  <text x="348.435,352.17,356.295,360.031,362.048,365.784,368.729,371.994,374.87100000000004,379.33,382.206,385.471,389.207,392.473,396.279,398.296,402.743,405.619,408.025,411.761,415.497,418.762,423.321,427.445,430.71,434.835,438.1,442.224,446.349,449.614,453.738,456.144,460.678,466.431,472.573,477.938,482.447,488.589,491.854,494.26,498.384,502.12,504.138,507.957,510.362,512.38,516.504,520.629,525.133,528.869,532.994,537.119,541.63,545.366,548.243,551.12,555.244,558.509,560.527,564.263,566.669,568.686,572.81" y="181.19600000000003" svg_rhmargin="576.934" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">analyses reveal stage dependent DNA methylation and association</text>
  <text x="348.435,350.84,354.965,358.582,361.847,363.865,365.882,370.006,372.024,375.289,379.413,381.819,385.944,389.68,392.085,396.21,400.334,402.458,406.582,410.318,412.336,415.601,419.337,421.354,424.963,427.369,431.105,434.37,436.776,440.9,443.777,446.654,450.303,452.32,456.445,460.053,464.178,467.054,470.32,474.056,476.932,479.338,482.956,485.362,489.486,495.628,499.753,502.629,505.506,507.52299999999997,511.187,515.7,523.171,528.5360000000001,532.161,537.526,541.262,545.387,548.652,551.917,554.794,558.408,562.533,566.657,570.782,574.906" y="190.154" svg_rhmargin="576.923" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">to clinico-pathological factors in breast tumors. BMC Cancer 2013;</text>
  <text x="348.435,352.559,356.683,358.701,362.825,366.95,371.074" y="199.111" svg_rhmargin="373.091" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">13:456.</text>
  <text x="332.05,334.456,338.581,342.705,345.111,348.434,354.187,357.452,359.47,362.735,366.859,370.984,372.696,377.21,379.227,380.917,386.282,390.406,394.531,398.655,401.921,406.045,409.31,412.187,415.923,417.651,420.528,425.892,427.909,429.556,433.292,437.416,439.433,443.169,446.905,451.03,454.76599999999996,456.483,462.707,464.724,466.403,469.668,472.074,473.716,477.452,479.47,481.487,483.184,488.937,495.079,500.444,502.118,508.26,511.525,513.931,518.055,521.791,523.809,527.628,530.034,532.051,536.175,540.3,541.97,546.094,548.971" y="208.125" svg_rhmargin="553.095" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[52] Dejeux E, Ronneberg JA, Solvang H, et al. DNA methylation pro</text>
  <text x="553.151" y="208.125" svg_rhmargin="557.275" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="557.233,559.251,561.268,565.392,569.128,570.839,572.856" y="208.125" svg_rhmargin="576.98" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ling in</text>
  <text x="348.435,352.559,356.683,360.808,364.932,367.809,371.933,376.058,378.075,381.427,383.444,387.569,389.874,392.28,395.156,398.422,402.157,404.563,407.828,411.953,414.363,418.488,421.364,423.382,429.524,433.259,436.136,439.872,442.254,444.271,448.396,451.661,455.397,457.414,459.432,463.168,465.497,469.232,473.357,477.093,480.829,484.953,488.285,491.55,495.675,497.979,502.103,504.98,508.245,511.981,514.857,517.2629999999999,519.633,522.039,526.164,532.306,536.43,540.555,543.431,546.308,548.715,550.732,554.856,558.122,562.246,564.652" y="217.082" svg_rhmargin="566.669" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">doxorubicin treated primary locally advanced breast tumours identi</text>
  <text x="566.701" y="217.082" svg_rhmargin="570.825" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="570.839,574.105" y="217.082" svg_rhmargin="576.982" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">es</text>
  <text x="348.435,352.559,356.683,360.419,363.684,365.701,367.255,370.991,374.256,378.381,381.646,384.523,386.019,389.755,392.632,395.508,399.633,402.898,404.915,408.651,411.057,414.322,418.447,419.975,425.729,427.746,430.152,434.277,435.792,438.668,442.793,445.669,449.405,451.423,455.159,458.895,460.912,462.435,466.171,470.296,474.421,475.927,478.333,481.21,484.475,488.211,490.617,496.759,500.024,504.148,506.55400000000003,508.126,511.003,514.268,517.145,521.269,525.393,529.518,532.395,535.66,537.677,539.191,546.663,550.787,552.8040000000001,554.327,559.691,563.427,567.552,570.817,574.082" y="226.039" svg_rhmargin="576.959" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">novel genes associated with survival and treatment response. Mol Cancer</text>
  <text x="348.435,352.559,356.683,360.808,364.932,366.95,371.074,373.091,377.289,381.413" y="234.99599999999998" svg_rhmargin="383.43" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2010;9:68.</text>
  <text x="332.05,334.456,338.581,342.705,345.111,348.434,352.558,355.823,359.948,363.68399999999997,366.574,374.046,376.063,378.876,382.612,386.736,390.002,394.127,396.96,401.473,403.49,406.371,413.843,417.108,421.233,424.058,427.794,429.811,432.675,435.94,438.346,441.179,444.915,446.932,448.949,451.78,457.145,461.269,464.146,467.022,470.288,472.305,476.041,478.536,480.554,484.678,488.803,491.631,495.756,499.021,501.427,507.18,510.445,513.711,517.836,520.712,526.077,530.202,535.955,538.796,544.939,548.204,550.61,554.735,558.471,560.488,564.224,566.63,568.647,572.867" y="243.95399999999995" svg_rhmargin="576.991" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[53] Feng W, Shen L, Wen S, et al. Correlation between CpG methylation</text>
  <text x="348.435,352.56,355.437" y="252.91099999999994" svg_rhmargin="359.561" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">pro</text>
  <text x="359.603" y="252.91099999999994" svg_rhmargin="363.727" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="363.742,365.759,369.025,371.902,373.379,377.115,381.239,385.364,386.814,390.939,395.063,397.94,404.081,408.206,412.33,415.59499999999997,417.142,420.019,423.284,426.549,429.814,433.939,436.345,440.469,443.346,444.862,447.739,450.145,453.881,456.287,460.411,463.288,464.76,466.777,470.902,472.413,476.538,479.414,482.679,486.415,489.292,491.698,493.161,496.426,500.162,504.286,507.617,510.882,513.758,516.635,518.652,520.145,524.657,527.534,530.799,534.535,537.412,539.818,541.289,546.654,550.39,554.514,557.779,561.044,563.9209999999999,565.438,570.803,574.068" y="252.91099999999994" svg_rhmargin="576.945" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">les and hormone receptor status in breast cancers. Breast Cancer Res</text>
  <text x="348.435,352.56,356.684,360.809,364.933,366.95,371.075,373.092,378.537,382.661,386.786" y="261.92499999999995" svg_rhmargin="388.803" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2007;9:R57.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.435,353.799,356.676,360.8,364.536,367.482,369.499,371.677,379.149,381.166,383.411,387.147,391.272,395.396,397.802,399.819,402.062,407.427,412.791,414.808,417.028,423.17,425.187,429.311,433.436,437.172,441.296,445.421,447.827,450.077,457.55,459.567,461.812,465.077,467.483,469.692,473.428,475.445,477.462,479.726,483.85,486.727,490.851,496.993,501.118,503.524,506.789,509.666,511.925,516.049,519.785,523.91,527.175,530.051,536.193,539.458,541.864,545.989,549.725,551.742,555.478,557.884,559.901,564.026,568.151,570.427,574.551" y="270.88199999999995" svg_rhmargin="576.957" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[54] Askari M, Sobti RC, Nikbakht M, et al. Promoter hypermethylation of</text>
  <text x="348.435,350.841,354.966,361.107,365.232,369.356,372.233,374.115,376.992,381.116,385.241,389.365,392.312,395.577,398.454,401.33,405.455,408.332,410.169,413.905,417.17,421.294,424.624,427.50100000000003,429.33,431.736,435.86,439.985,444.109,446.127,451.491,456.938,461.063,462.89,466.626,470.751,474.876,476.723,480.847,484.972,489.096,491.179,493.584,499.726,505.091,509.215,512.951,515.357,517.374,519.296,522.561,526.297,529.173,532.439,534.845,538.11,542.234,546.359,548.765,551.641,555.766,557.783,559.658,562.534,564.94,569.065,573.263" y="279.83900000000006" svg_rhmargin="576.999" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">tumour suppressor genes (p14/ARF and p16/INK4a): case-control study</text>
  <text x="348.435,350.453,354.578,357.109,363.251,367.376,370.252,372.658,376.783,379.274,381.68,385.805,389.929,391.947,395.682,399.807,402.346,406.471,410.595,414.72,418.844,420.862,424.597,427.003,429.021,433.145,437.27,439.287,441.858,449.33,453.454,455.471,457.958,462.471,464.489,468.613,470.63,473.151,478.515,481.781,485.906,488.4,492.524,496.649,500.773,504.898,506.915,511.039,515.164,517.254,521.378,525.503,529.627" y="288.796" svg_rhmargin="533.751" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in North Indian population. Mol Biol Rep 2013;40:4921</text>
  <text x="533.764" y="288.796" svg_rhmargin="537.5" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="537.505,541.631" y="288.796" svg_rhmargin="543.648" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.435,352.17,356.295,360.031,362.907,369.049,372.78499999999997,376.042,381.796,383.813,386.984,394.456,396.474,399.35,402.616,406.352,409.547,413.283,415.3,418.504,422.629,425.505,429.241,432.118,435.854,439.979,443.22,448.585,452.709,454.726,457.903,461.168,463.574,466.803,470.539,472.557,474.574,477.744,481.869,484.746,488.87,495.012,499.136,501.542,504.807,507.684,510.907,515.032,518.768,522.892,526.157,529.104,535.246,538.511,540.917,545.042,548.777,550.795,554.531,556.937,558.954,563.079,567.204,570.43,574.555" y="297.754" svg_rhmargin="576.961" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[55] Sharma G, Mirza S, Prasad CP, et al. Promoter hypermethylation of</text>
  <text x="348.435,352.56,356.684,360.809,363.214,369.356,374.721,378.934,384.298,386.315,387.777,391.902,396.026,400.15,405.515,410.88,415.004,417.021,418.502,423.867,427.603,430.868,432.886,434.903,439.028,444.781,448.906,450.418,454.154,458.279,462.404,463.854,467.59,469.608,471.625,474.031,478.156,479.671,481.688,485.813,487.267,490.144,493.409,496.286,500.41,506.552,508.016,511.751,515.876,520.001,521.507,523.913,528.038,534.18,538.304,541.1809999999999,542.652,548.405,554.547,559.912,561.416,563.822,566.698,570.823" y="306.711" svg_rhmargin="576.965" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from</text>
  <text x="348.435,352.56,355.436,358.702,362.437,365.314,367.72,370.26,373.526,377.261,381.386,384.651,387.916,390.793,393.333,397.457,401.193,403.599,405.616,408.881,413.006,415.412,418.288,420.305,422.867,427.38,429.397,431.803,435.068,437.55,441.286,444.551,446.568,449.115,453.239,457.364,461.488,465.612,467.63,471.754,475.879,477.896,482.02,486.145,490.269" y="315.668" svg_rhmargin="494.393" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast cancer patients. Life Sci 2007;80:1873</text>
  <text x="494.419" y="315.668" svg_rhmargin="498.155" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="498.16,502.286,506.411" y="315.668" svg_rhmargin="508.428" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">81.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.435,354.188,358.312,364.454,366.471,370.596,374.332,378.536,381.801,385.066,389.987,395.741,397.758,402.686,406.422,408.439,410.456,414.192,417.928,422.867,425.744,427.761,432.731,438.485,442.221,445.097,448.362,450.38,454.116,459.035,461.912,469.384,471.401,476.382,479.648,482.05400000000003,486.983,490.72,492.737,494.754,499.682,503.807,506.684,509.949,513.685,517.421,519.438,522.703,526.828,530.093,533.358,538.344,542.468,544.8739999999999,549.795,553.531,557.656,560.921,563.797,566.674,570.41,574.534" y="324.682" svg_rhmargin="576.94" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[56] Dominguez G, Silva J, Garcia JM, et al. Prevalence of aberrant</text>
  <text x="348.435,354.577,357.842,360.248,364.373,368.109,370.126,373.945,376.351,378.368,382.492,386.617,388.117,392.242,394.648,396.111,400.235,404.359,408.484,413.849,419.213,423.338,424.852,428.976,432.712,435.977,438.854,440.384,444.508,448.633,452.757,455.163,461.305,466.67,470.794,474.53,476.041,478.058,482.183,483.637,486.514,490.638,496.78,500.04499999999996,501.551,505.675,509.8,516.007,519.742,523.867,525.304,529.428,532.305,534.322,540.464,544.2,547.077,550.813,552.344,554.75,558.875,565.017,569.141,572.018,574.894" y="333.639" svg_rhmargin="576.911" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">methylation of p14ARF over p16INK4a in some human primary tumors.</text>
  <text x="348.435,355.907,360.032,362.437,366.173,368.579,371.111,376.475,379.741,382.618,385.113,389.238,393.362,397.487,401.611,403.707,407.832,411.956,416.08,418.098" y="342.596" svg_rhmargin="422.222" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Mutat Res 2003;530:9</text>
  <text x="422.249" y="342.596" svg_rhmargin="425.985" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="425.991,430.116,434.241" y="342.596" svg_rhmargin="436.258" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">17.</text>
  <text x="332.051,334.457,338.581,342.706,345.112,348.435,352.17,354.188,356.205,359.941,363.67699999999996,367.766,370.642,372.659,376.723,380.459,382.476,384.493,388.229,391.965,396.054,398.931,406.402,408.419,412.55,418.304,422.429,428.57,430.588,434.712,438.448,442.573,445.838,449.103,453.197,458.95,460.967,465.045,468.31,470.716,474.795,478.531,480.549,482.566,486.643,492.008,496.133,500.257,503.593,507.718,513.859,515.877,518.283,522.019,526.143,528.549,532.617,535.883,540.007,544.132,547.073,550.338,553.215,556.092,558.109,562.234,566.359,570.429,574.554" y="351.554" svg_rhmargin="576.96" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[57] Silva J, Silva JM, Dominguez G, et al. Concomitant expression of</text>
  <text x="348.435,352.56,356.684,360.809,363.214,369.356,374.721,378.934,382.67,387.041,390.776,394.901,399.026,403.481,407.605,411.73,415.854,421.219,426.583,430.708,435.169,437.187,441.312,445.714,449.839,452.715,454.733,460.875,464.61,467.487,471.223,475.702,479.827,482.703,485.969,489.704,492.581,494.987,499.455,502.72,506.456,510.581,513.846,517.111,519.9879999999999,524.455,528.191,532.315,536.44,540.839,544.574,548.699,552.435,554.452,558.188,561.133,563.15,566.0269999999999,570.43,574.554" y="360.511" svg_rhmargin="576.96" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">p16INK4a and p14ARF in primary breast cancer and analysis of</text>
  <text x="348.435,350.453,354.577,358.313,361.578,363.984,366.001,369.737,373.473,375.879,377.897,382.021,386.146,388.74,394.883,398.148,401.413,405.538,409.274,413.398,415.415,418.292,424.434,427.311,429.328,431.88,434.757,437.266,441.391,445.127,447.533,451.657,455.782,457.799,460.282,464.406,468.531,472.655,476.78,478.876,483.001,487.125,491.25,493.267,497.391,501.516" y="369.468" svg_rhmargin="505.64" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">inactivation mechanisms. J Pathol 2003;199:289</text>
  <text x="505.644" y="369.468" svg_rhmargin="509.38" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="509.386,513.511,517.636" y="369.468" svg_rhmargin="519.653" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">97.</text>
  <text x="332.052,334.458,338.582,342.707,345.113,348.435,353.8,357.065,363.207,365.224,367.242,370.978,375.192,379.316,383.052,386.788,391.746,397.11,402.475,404.492,409.49,414.854,418.979,422.244,425.98,427.997,432.122,435.858,439.594,444.58,449.945,452.351,454.368,459.376,463.112,465.518,468.394,471.659" y="378.482" svg_rhmargin="473.676" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[58] Zemliakova VV, Zhevlova AI, Strel</text>
  <text x="473.727" y="378.482" svg_rhmargin="475.744" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">’</text>
  <text x="475.711,481.853,483.871,488.07,492.195,495.931,500.882,506.247,511.612,513.629,518.626,521.892,524.298,529.284,533.02,535.038,537.0550000000001,541.983,544.389,549.753,553.878,558.082,562.207,565.083,571.225,574.961" y="378.482" svg_rhmargin="576.978" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Nikov VV, et al. [Abnormal</text>
  <text x="348.437,354.579,357.844,360.25,364.374,368.11,370.127,373.946,376.352,378.37,382.494,386.619,388.062,392.186,394.592,396.112,398.989,402.254,405.99,409.255,412.132,415.867,417.884,419.354,421.76,425.884,432.026,436.15,439.027,440.498,443.375,447.499,451.624,455.748,458.695,461.96,464.837,467.713,471.838,474.71500000000003,476.155,479.891,483.156,487.281,490.611,493.488,494.92,496.937,501.062,502.573,505.45,509.574,513.699,516.575,520.311,524.436,526.453,529.718,531.201,535.325,538.202,541.467,545.203,548.079,550.4849999999999,551.948,555.214,558.949,563.074,566.404,569.669,572.546,574.952" y="387.439" svg_rhmargin="576.969" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">methylation of several tumor suppressor genes in sporadic breast cancer].</text>
  <text x="348.437,355.909,360.033,362.05,364.593,369.106,371.123,375.248,377.265,379.785,382.191,389.663,393.788,396.664,400.789,403.195,405.692,409.816,413.94,418.065,422.189,424.207,428.331,432.456,434.545,438.67,442.794" y="396.396" svg_rhmargin="446.918" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Mol Biol (Mosk) 2003;37:696</text>
  <text x="446.912" y="396.396" svg_rhmargin="450.648" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="450.654,454.778,458.903,463.027" y="396.396" svg_rhmargin="465.044" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">703.</text>
  <text x="332.053,334.459,338.584,342.708,345.11400000000003,348.437,352.95,357.074,360.81,363.687,367.812,370.829,376.971,378.988,382.054,387.419,389.436,391.842,393.859,397.984,400.001,402.878,404.895,409.02,412.099,414.975,416.992,419.978,426.12,429.385,433.51,436.775,442.994,445.011,447.88800000000003,450.874,454.998,457.015,460.057,463.322,465.728,468.731,472.467,474.484,476.501,479.559,487.03,490.296,492.701,496.826,500.562,502.579,506.315,508.721,510.738,514.863,518.988,522.018,526.142,529.019" y="405.353" svg_rhmargin="533.143" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[59] Buyru N, Altinisik J, Ozdemir F, et al. Methylation pro</text>
  <text x="533.199" y="405.353" svg_rhmargin="537.323" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="537.337,539.355,542.62,545.497,548.505,550.523,554.648,557.69,561.814,564.691,567.956,571.692,574.569" y="405.353" svg_rhmargin="576.975" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">les in breast</text>
  <text x="348.437,351.703,355.439,359.563,362.828,366.093,368.97,370.987,373.55,378.915,382.651,386.775,390.04,393.306,396.183,398.72,401.126,405.25,408.986,412.251,415.128,417.534,420.034,424.159,428.283,432.408,436.532,438.549,442.674,446.798,448.888,453.013,457.137" y="414.311" svg_rhmargin="461.261" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer. Cancer Invest 2009;27:307</text>
  <text x="461.256" y="414.311" svg_rhmargin="464.992" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="464.998,469.123,473.248" y="414.311" svg_rhmargin="475.265" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">12.</text>
  <text x="332.053,334.459,338.584,342.708,345.11400000000003,348.437,352.95,354.967,357.844,361.968,365.704,369.828,373.56399999999996,375.42,382.892,384.909,386.758,392.123,395.859,397.876,401.612,405.348,409.472,413.597,415.442,418.319,422.832,424.849,426.666,432.891,437.016,438.855,444.608,450.832,452.849,454.671,457.937,460.343,462.211,465.947,467.965,469.98199999999997,471.792,479.263,483.388,485.405,488.67,491.936,496.06,498.077,501.893,504.77,506.542,510.278,514.402,518.138,520.156,523.892,526.836,528.854,531.731,533.526,537.65,540.0559999999999,541.916,544.322,548.446,551.711,553.538,555.944,562.085,567.45,571.575" y="423.268" svg_rhmargin="576.94" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[60] Bisogna M, Calvano JE, Ho GH, et al. Molecular analysis of the INK4A</text>
  <text x="348.437,352.173,356.298,360.423,363.857,366.263,372.405,377.769,381.894,386.407,389.821,393.557,396.822,400.946,404.211,407.622,409.639,413.763,417.029,419.046,422.474,424.491,428.616,431.998,436.123,440.247,446.389,450.125,454.25,457.678,461.802,464.679,467.944,471.68,474.557,476.963,480.353,483.619,487.355,491.479,494.809,498.074,500.951,504.333,507.599,510.864,512.881,514.898,518.336,520.353,522.37,526.495,529.76,532.637,536.023,539.759,543.883,548.008,551.442,555.567,558.444,560.461,566.603,570.339,573.215" y="432.225" svg_rhmargin="576.951" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">and INK4B gene loci in human breast cancer cell lines and primary</text>
  <text x="348.437,351.703,355.439,358.315,361.58,363.598,367.722,371.847,377.988,381.724,384.601,386.618,389.196,394.561,398.297,402.421,405.686,408.952,411.829,414.366,420.119,423.384,427.508,430.774,433.18,435.68,441.045,444.781,447.187,451.383,455.119,458.384,462.509,465.774,468.18,470.657,474.782,478.906,483.031,487.155,489.172,493.297,497.421,501.546,503.65,507.774,511.899" y="441.239" svg_rhmargin="516.023" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinomas. Cancer Genet Cytogenet 2001;125:131</text>
  <text x="516.021" y="441.239" svg_rhmargin="519.757" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="519.763,523.888" y="441.239" svg_rhmargin="525.905" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="332.053,334.459,338.584,342.708,345.11400000000003,348.437,352.95,355.826,359.092,363.216,366.481,368.499,374.64,378.376,382.501,385.378,388.288,393.653,398.555,400.572,403.481,407.217,410.482,414.218,418.342,422.078,425.343,429.079,432.344,435.226,440.591,442.608,445.487,450.0,453.736,456.613,459.019,462.284,464.301,467.178,470.09,475.455,480.82,482.837,485.679,488.945,491.351,494.24,497.976,499.993,502.01,504.898,509.411,511.817,514.222,517.488,520.753,523.159,525.176,528.912,532.177,536.302,539.567,542.444,545.3209999999999,548.264,552.389,554.795,557.675,561.799,564.676,567.941,571.677,574.554" y="450.196" svg_rhmargin="576.96" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[61] Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast</text>
  <text x="348.438,351.703,355.439,359.563,362.828,366.093,368.97,370.83,373.706,377.831,380.707,384.443,387.708,389.726,391.743,393.761,397.497,401.621,404.886,408.151,410.058,412.076,416.201,417.995,422.508,427.872,433.237,438.602,442.726,444.744,448.869,450.761,454.497,457.762,461.886,465.151,466.974,473.116,477.24,479.646,483.382,485.788,487.805,491.93,496.055,497.926,501.191,504.927,507.803,510.68,512.697,515.963,518.839,521.716,523.549,527.285,531.409,535.534,537.381,543.135,547.26,553.402,556.667,560.792,562.665,568.418,570.436,572.842" y="459.153" svg_rhmargin="576.966" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer surveillance in BRCA1/2 gene mutation carriers and women with</text>
  <text x="348.438,352.562,354.579,358.315,362.44,364.991,367.396,371.132,377.274,379.292,381.309,383.326,387.062,389.079,391.577,394.454,396.471,399.348,403.473,405.49,408.017,410.894,413.403,418.768,420.785,422.803,426.928,429.447,435.589,439.713,442.978,447.103,449.12,451.669,455.793,459.918,464.042,468.166,470.184,474.308,478.433,480.45,484.574,488.699" y="468.111" svg_rhmargin="492.823" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">high familial risk. J Clin Oncol 2001;19:924</text>
  <text x="492.891" y="468.111" svg_rhmargin="496.627" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="496.632,500.758,504.883" y="468.111" svg_rhmargin="506.9" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">30.</text>
  <text x="332.054,334.46,338.584,342.709,345.115,348.438,355.909,360.034,364.158,366.176,368.581,372.706,376.831,378.255,383.157,385.174,386.589,391.955,394.831,398.096,402.221,405.098,409.222,412.958,418.711,420.149,425.051,427.068,428.483,434.707,438.443,442.568,443.959,449.325,451.342,452.747,456.012,458.418,459.833,463.569,465.586,467.603,469.016,473.529,477.654,479.671,483.407,486.672,490.797,494.062,496.468,498.485,501.75,503.199,505.217,508.482,511.358,513.376,517.5,521.625,524.502,525.931,529.667,532.073,533.471,535.877,540.002,543.2669999999999,544.696,550.92,555.045,559.17,560.569,562.587,566.711,569.976,574.101" y="477.068" svg_rhmargin="576.978" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[62] Moulton T, Crenshaw T, Hao Y, et al. Epigenetic lesions at the H19 locus</text>
  <text x="348.438,350.456,354.581,357.112,364.584,366.601,368.619,374.761" y="486.025" svg_rhmargin="377.638" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in Wilms</text>
  <text svg_rhmargin="379.709" x="377.692,379.709" y="486.025" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">’ </text>
  <text x="382.17,384.576,388.701,394.843,398.967,403.091,405.968,408.53,412.655,416.391,418.796,420.814,424.079,428.203,430.609,433.486,435.503,438.008,444.15,447.886,450.29200000000003,452.804,458.558,461.823,465.947,469.212,471.618,474.176,478.3,482.425,486.549,490.674,492.691,496.815,498.833,502.957,507.082" y="486.025" svg_rhmargin="511.206" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">tumour patients. Nat Genet 1994;7:440</text>
  <text x="511.259" y="486.025" svg_rhmargin="514.995" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="515.001,519.126" y="486.025" svg_rhmargin="521.143" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="332.054,334.46,338.584,342.709,345.115,348.438,353.802,355.82,359.556,362.432,366.557,368.392,374.145,381.617,383.634,385.455,392.927,396.192,401.945,406.147,408.164,411.041,414.306,416.124,423.596,428.109,430.126,431.94,435.676,438.082,441.347,444.224,448.348,450.366,454.491,456.316,459.193,462.458,465.723,468.988,473.113,475.519,479.728,482.605,485.482,487.268,491.004,495.128,499.253,501.101,505.226,507.632,511.756,515.021,517.8979999999999,519.695,523.819,526.696,530.82,534.556,538.742,542.867,545.743,548.149,550.167,553.432,555.239,557.645,561.381,564.646,567.052,571.177,574.053" y="495.039" svg_rhmargin="576.93" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[63] Clark GM, McGuire WL. Steroid receptors and other prognostic factors</text>
  <text x="348.438,350.456,354.581,357.112,361.237,364.113,366.131,372.273,376.008,378.885,382.621,385.117,389.241,392.118,395.383,399.119,402.066,404.472,406.942,410.207,413.943,418.067,421.332,424.598,427.474,429.491,432.054,435.79,439.055,445.197,447.215,451.34,453.823,459.965,464.089,467.428,471.553,473.57,476.045,480.17,484.295,488.419,492.544,494.561,498.686,502.81,504.827,508.952" y="503.996" svg_rhmargin="513.076" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">in primary breast cancer. Semin Oncol 1988;15:20</text>
  <text x="513.13" y="503.996" svg_rhmargin="516.866" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="516.872,520.997" y="503.996" svg_rhmargin="523.014" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="332.054,334.46,338.584,342.709,345.115,348.438,353.802,357.538,361.663,365.399,367.712,373.077,375.094,377.349,381.473,383.879,388.004,390.41,393.675,396.94,399.231,404.595,406.612,408.868,414.233,418.357,421.622,425.818,429.942,431.959,435.225,439.35,441.634,449.106,451.123,453.368,456.634,459.04,461.305,465.041,467.058,469.075,471.339,477.092,483.234,488.599,490.897,497.039,500.304,502.71,506.834,510.57,512.588,516.323,518.729,520.747,524.966,529.091,531.316,535.052,537.928,540.805,544.541,548.277,550.59,554.326,558.45,562.186,564.204,567.94,570.816,574.081" y="512.953" svg_rhmargin="576.958" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[64] Yang R, Pfutze K, Zucknick M, et al. DNA methylation array analyses</text>
  <text x="348.438,350.456,354.58,357.845,361.97,364.376" y="521.9100000000001" svg_rhmargin="366.393" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">identi</text>
  <text x="366.466" y="521.9100000000001" svg_rhmargin="370.59" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="370.605,373.87,377.995,381.603,385.727,388.604,391.869,395.605,398.481,400.887,404.561,407.826,411.562,415.687,418.952,422.217,425.094,427.5,431.235,434.112,436.989,441.113,444.47,446.487,450.223,452.629,455.894,460.019,463.63,469.854,475.219,480.584,485.172,489.297,492.882,499.025,502.29,504.696,508.82,512.556,514.574,518.392,520.798,522.816,526.94,531.065,534.719,536.737,540.862,544.47,548.594,551.86,554.736,556.828,560.953,565.077,568.342,571.219,574.955" y="521.9100000000001" svg_rhmargin="576.972" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ed breast cancer-associated HYAL2 methylation in peripheral</text>
  <text x="348.438,352.563,354.58,358.705,362.829,366.953,368.96999999999997,371.51,373.916,378.041,380.447,382.962,385.839,388.347,393.713,397.449,401.573,404.838,408.104,410.981,413.518,417.642,421.766,425.891,430.015,432.033,436.157,440.281,444.406,446.423,450.548,454.672,458.797" y="530.8679999999999" svg_rhmargin="462.921" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">blood. Int J Cancer 2015;136:1845</text>
  <text x="462.957" y="530.8679999999999" svg_rhmargin="466.693" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="466.699,470.823,474.948" y="530.8679999999999" svg_rhmargin="476.965" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">55.</text>
  <text x="332.054,334.46,338.584,342.709,345.115,348.438,352.562,356.298,360.422,364.158,366.748,372.113,374.13,376.669,379.546,381.563,385.299,389.424,391.975,397.34,402.704,404.721,407.281,411.017,415.141,418.406,422.531,425.138,430.891,435.015,437.032,439.593,442.859,445.265,447.814,451.55,453.567,455.584,458.132,462.256,465.133,469.257,475.399,479.523,481.929,485.194,488.071,490.671,496.812,500.078,502.483,506.608,510.344,512.361,516.097,518.503,520.52,524.74,528.865,531.372,535.498,537.904,540.444,542.85,546.974,550.239,552.802,555.679,558.944,561.35,563.368,567.492,571.617,573.721" y="539.825" svg_rhmargin="576.986" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[65] Fang C, Jian ZY, Shen XF, et al. Promoter methylation of the retinoic</text>
  <text x="348.438,352.174,355.439,357.457,361.582,365.218,368.095,371.36,374.625,377.891,382.015,384.421,388.631,391.508,395.094,399.219,402.484,404.958,408.694,412.819,416.409,418.815,424.18,429.545,434.909,439.034,442.299,444.705,448.441,452.565,454.971,458.699,461.105,463.982,467.599,471.335,474.212,477.088,481.213,484.478,486.495,490.231,492.637,495.902,500.027,503.71,509.463,511.48,513.886,518.011,521.68,523.697,527.822,531.087,533.964,537.229,540.965,543.841,547.107,551.232,554.9,557.776,559.794,562.67,566.795,570.433,574.557" y="548.8389999999999" svg_rhmargin="576.963" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">acid receptor beta2 (RARbeta2) Is associated with increased risk of</text>
  <text x="348.438,352.563,355.439,358.705,362.44,365.317,367.723,369.639,372.905,376.641,380.765,384.03,387.295,390.172,392.189,394.129,397.865,399.742,403.866,409.231,411.637,415.373,422.845,428.21000000000004,430.127,433.392,437.516,443.658,447.782,449.8,451.817,455.553,459.678,462.084,464.026,470.169,473.434,475.84,479.576,481.982,485.717,489.842,493.578,495.595,499.331,502.208,504.225,507.102,509.11899999999997,511.078,515.202,519.715,523.839,527.575,529.445,535.587,541.728,546.241,548.152,552.276,556.401,560.525,564.65,566.667,570.792,574.916" y="557.796" svg_rhmargin="576.933" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">breast cancer: a PRISMA compliant meta-analysis. PLoS ONE 2015;10:</text>
  <text x="348.438,351.703,355.828,359.952,364.077,368.201,372.326,376.45,380.637" y="566.7529999999999" svg_rhmargin="382.654" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">e0140329.</text>
  <text x="332.054,334.46,338.584,342.709,345.115,348.438,353.802,357.927,359.944,364.069,367.334,370.599,372.7,376.825,379.106,384.472,386.489,388.858,393.371,396.637,399.902,404.027,406.318,412.072,414.089,416.409,422.162,426.287,429.55199999999996,431.885,434.762,436.779,439.142,442.407,444.813,447.135,450.871,452.889,454.906,457.226,459.632,463.756,467.881,469.898,473.634,475.652,479.776,483.9,487.636,489.653,492.033,494.909,498.175,500.58,503.457,507.582,509.987,512.864,516.6,520.724,523.601,527.726,531.85,534.727,538.851,542.976,545.376,547.394,551.518,553.924,557.189,560.925,563.802,567.538,571.662,574.068" y="575.71" svg_rhmargin="576.945" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[66] Coluccio A, Ecco G, Duc J, et al. Individual retrotransposon integrants</text>
  <text x="348.438,352.174,355.051,358.316,360.91,365.035,367.052,369.458,371.864,375.129,378.006,381.271,385.395,387.801,389.819,393.554,395.572,397.701,401.437,403.993,407.259,411.383,415.507,417.913,420.79,424.914,426.932,428.949,432.214,436.339,438.97,443.095,446.831,449.402,454.766,460.131,464.256,468.38,470.397,475.762,481.127,485.251,489.376,491.782,495.999,499.264,503.388,506.653,510.778,514.902,518.167,522.292,524.698,527.291,531.415,533.432,536.309,538.715,542.839,546.964,550.229,552.801,558.943,562.208,564.614,568.738,572.474,574.492" y="584.668" svg_rhmargin="576.898" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">are differentially controlled by KZFP/KAP1-dependent histone methyl-</text>
  <text x="348.438,352.174,354.58,356.598,360.722,364.846,366.863,371.17,376.924,383.066,388.431,392.712,398.854,402.119,404.525,408.65,412.386,414.403,418.139,420.545,422.562,426.782,430.907,435.116,438.851,442.976,447.101,451.385,456.287,460.8,465.701,468.107,474.249,477.514,481.639,483.656,487.392,489.798,493.164,497.289,501.498,505.623,509.359,513.483,516.36,520.546,524.67,528.406,534.548,537.813,540.219,544.344,548.079,550.097,553.833,556.239,558.256,562.381,566.506,570.828,572.846" y="593.625" svg_rhmargin="576.97" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ation, DNA methylation and TET-mediated hydroxymethylation in</text>
  <text x="348.438,352.563,356.299,358.316,362.052,365.317,367.826,371.091,377.233,381.431,384.308,388.044,392.168,396.293,398.31,401.575,404.05,406.927,409.333,412.598,418.74,421.284,424.549,427.814,429.832,431.849,434.726,436.743,439.254,443.767,447.892,449.909,453.71,456.975,461.1,464.365,466.771,468.788,472.053,474.93,477.463,482.827,486.952,489.829,493.953,500.095,503.831,506.237,508.254,512.379,514.934,519.058,523.183,527.307,531.432,533.449,537.573,541.698,543.715,547.84" y="602.582" svg_rhmargin="549.857" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">naïve embryonic stem cells. Epigenetics Chromatin 2018;11:7.</text>
  <text x="332.054,334.46,338.584,342.709,345.115,348.438,353.802,357.538,361.663,363.12,367.245,369.262,370.66,374.396,378.52,381.786,385.911,387.327,393.469,395.486,396.907,401.031,404.767,408.892,412.628,414.084,416.961,422.714,424.731,426.158,429.424,431.83,433.245,436.981,438.998,441.015,442.428,447.793,449.231,452.967,454.985,458.25,460.267,464.392,468.516,471.39300000000003,472.814,474.831,478.956,483.08,487.205,488.63,492.755,495.161,496.567,498.973,502.708,505.114,507.52,511.256,512.723,516.459,519.724,521.741,525.866,528.272,532.396,534.414,538.538,542.663,544.68,548.804,552.54,553.992,558.117,560.993,565.118,567.524,570.789,572.806" y="611.596" svg_rhmargin="576.93" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[67] Yan F, Shen N, Pang JX, et al. A vicious loop of fatty acid-binding protein</text>
  <text x="348.438,352.563,355.015,358.751,362.875,367.0,369.414,375.167,381.309,386.67400000000004,389.085,395.227,398.492,400.898,405.022,408.758,410.775,413.181,416.058,419.794,423.918,426.896,429.302,432.567,435.444,439.179,442.056,445.32099999999997,447.757,451.882,454.277,458.401,461.278,465.402,471.624,475.749,478.155,481.42,484.297,486.704,490.44,493.705,497.829,500.235,503.5,505.921,512.063,515.799,519.064,521.082,525.206,527.223,531.348,533.812,535.829,539.095,543.219,547.344,550.609,556.828,558.845,562.581,564.991,568.727,572.852" y="620.553" svg_rhmargin="576.976" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">4 and DNA methyltransferase 1 promotes acute myeloid leukemia and</text>
  <text x="348.438,352.174,355.439,357.845,360.72200000000004,363.234,366.97,369.84700000000004,372.362,376.098,378.597,381.003,385.128,388.393,391.27,395.006,399.13,402.395,406.52,408.925,410.943,414.20799999999997,416.748,419.154,422.89,425.767,429.503,432.768,435.174,437.191,439.764,444.277,447.542,451.666,455.791,459.056,465.198,467.215,470.95099999999996,473.493,477.617,481.742,485.866,489.991,492.008,496.132,500.257,502.274,506.399,510.523" y="629.51" svg_rhmargin="514.647" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">acts as a therapeutic target. Leukemia 2018;32:865</text>
  <text x="514.718" y="629.51" svg_rhmargin="518.454" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="518.46,522.585,526.71" y="629.51" svg_rhmargin="528.727" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text x="332.055,334.461,338.585,342.71,345.116,348.438,353.803,357.927,361.193,365.318,368.563,373.928,375.945,379.107,381.984,386.108,390.232,393.109,395.515,398.78,402.905,406.147,409.883,415.248,417.265,420.433,424.558,427.823,431.947,435.683,438.914,444.28,446.29699999999997,449.459,452.724,455.13,458.36,462.095,464.113,466.13,469.301,474.665,478.79,482.526,484.543,488.279,491.156,493.173,496.05,499.289,503.413,505.819,508.982,514.736,520.878,526.243,529.447,535.589,538.854,541.26,545.384,549.12,551.138,554.957,557.363,559.38,563.504,567.629,570.83,572.847" y="638.468" svg_rhmargin="576.971" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[68] Koch A, Joosten SC, Feng Z, et al. Analysis of DNA methylation in</text>
  <text x="348.439,351.704,355.44,359.565,362.83,366.095,368.971,370.988,373.552,375.569,379.694,382.959,386.695,389.101,391.118,395.242,399.367,401.896,404.773,408.038,411.774,413.791,416.668,418.685,421.091,424.356,428.481,430.498,433.074,439.217,442.953,445.359,447.871,453.235,456.501,460.23699999999997,462.723,468.089,470.106,472.123,476.248,478.767,484.909,489.034,492.299,496.423,498.44,500.989,505.114,509.238,513.362,517.487,519.504,523.629,527.753,529.771,533.895,538.019" y="647.425" svg_rhmargin="542.143" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cancer: location revisited. Nat Rev Clin Oncol 2018;15:459</text>
  <text x="542.214" y="647.425" svg_rhmargin="545.95" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="545.956,550.081,554.205" y="647.425" svg_rhmargin="556.222" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">66.</text>
  <text x="332.055,334.461,338.585,342.71,345.116,348.438,353.803,357.927,362.052,366.177,368.62,376.091,378.108,380.524,384.649,388.385,390.402,394.138,398.262,401.528,405.264,407.678,413.043,420.515,424.251,426.268,428.71,433.224,436.96,442.71299999999997,445.094,447.971,453.336,455.353,457.792,462.306,466.431,469.696,473.82,476.697,479.103,482.056,486.18,489.445,492.71" y="656.3820000000001" svg_rhmargin="494.727" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[69] Zhou M, Palanca AMS, Law JA. Locus-speci</text>
  <text x="494.762" y="656.3820000000001" svg_rhmargin="498.886" style="fill:#171615;font-family:LJLAMI+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="498.844,502.109,504.514,507.779,511.903,516.028,518.434,521.31,525.435,527.452,529.91,534.035,536.4409999999999,538.868,541.274,545.398,548.663,551.056,555.18,558.4449999999999,560.863,564.988,569.112,572.848" y="656.3820000000001" svg_rhmargin="576.972" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">c control of the de novo</text>
  <text x="348.439,354.192,360.334,365.699,368.053,374.195,377.46,379.866,383.991,387.726,389.744,393.48,395.886,397.903,402.027,406.152,408.529,412.653,416.389,418.795,422.919,428.673,432.409,436.145,438.46,440.477,444.602,446.907,452.272,455.149,458.885,463.009,465.027,469.151,473.276,477.4,480.354,482.371,485.248,487.553,491.678,495.414,497.701,500.107,504.231,507.496,509.833,515.198,519.71,525.075,528.811,532.547,537.912,540.274,542.68,546.416,552.558,554.575,556.593,560.329,562.346,564.65,570.793,574.529" y="665.396" svg_rhmargin="576.935" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">DNA methylation pathway in Arabidopsis by the CLASSY family. Nat</text>
  <text x="348.439,354.192,357.457,361.582,364.847,367.253,369.811,373.935,378.059,382.184,386.308,388.326,392.45,396.574,398.592,402.716,406.841" y="674.353" svg_rhmargin="410.965" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Genet 2018;50:865</text>
  <text x="411.027" y="674.353" svg_rhmargin="414.763" style="fill:#171615;font-family:LJLBEN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="414.769,418.894,423.02" y="674.353" svg_rhmargin="425.037" style="fill:#171615;font-family:LJLAMH+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">73.</text>
  <text svg_rhmargin="195.665" x="71.887,77.777,79.188,81.808,85.873,90.105,94.664,97.341,101.9,103.311,107.71,111.942,116.341,118.94,125.492,129.557,134.116,135.526,139.591,141.002,145.234,149.299,151.878,153.783,158.182,162.582,166.981,171.381,173.286,175.914,180.314,184.714,186.866,191.265,195.664" y="9.870999999999981" style="fill:#171615;font-family:LJLAKP+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Qi and Xiong Medicine (2018) 97:51 </text>
  <text x="542.723,549.944,554.503,559.317,561.31,565.869,567.861,572.508" y="9.870999999999981" svg_rhmargin="577.067" style="fill:#171615;font-family:LJLAKO+AdvOT34fe1490.B;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Medicine</text>
  <text x="320.032,324.432" y="739.625" svg_rhmargin="328.832" style="fill:#171615;font-family:LJLBCM+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">10</text>
 </g>
</svg>
